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Abstract 
Many Gram-negative bacteria assemble a complex nanomachine, the type III secretion system 
(T3SS) to inject virulence proteins directly into eukaryotic cells to initiate infection.  The T3SS 
is composed of structural and non-structural proteins.  The structural component of the T3SS is a 
needle apparatus composed of a membrane embedded basal structure, an external needle, a tip 
complex that caps the needle and a translocon.  Chaperones are small cytoplasmic proteins that 
assist in the assembly and proper operation of the T3SS.  They serve as important regulators of 
secretion and sequester effector proteins and other structural components while inside the 
bacterial cytosol. 
Yersinia pestis is the causative agent of plague that in the past has caused worldwide pandemics, 
and is considered a potential agent of bioterrorism.  Pseudomonas aeruginosa is an opportunistic 
pathogen that is most frequently associated with nosocomial infections of immuno-compromised 
patients.  A key factor in the pathogenesis of Y. pestis and P. aeruginosa is that they harbor the 
T3SS, which enables them to inject virulent effector proteins that hijack the host cellular 
machinery and facilitate the survival of these bacteria inside the host cells. 
An important component of the Y. pestis and the P. aeruginosa T3SS is the LcrG/PcrG family of 
chaperone proteins, which form a complex with the T3SS tip proteins LcrV and PcrV.  They also 
function as important regulators of effector secretion and facilitate the translocation of effector 
proteins into the targeted host cells.  The atomic structures of members of the LcrG/PcrG family 
of chaperone proteins are currently unknown.  Further, how they interact with their cognate tip 
proteins is poorly understood.  Here, I show by CD and NMR spectroscopy that the chaperones, 
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LcrG and PcrG, lack compact tertiary structures.  However, they are not completely disordered 
but contain secondary structure dominated by at least two major α-helices from residues Val-16 
to Gly-41 and Glu-55 to Ser-76 in PcrG, and residues Asp-7 to Gly-38 and Ala-59 to Arg-73 in 
LcrG.  NMR backbone dynamics studies show that the helices in the chaperones have semi-rigid 
flexibility and they tumble as a single entity with similar backbone dynamics.  Thus the 
LcrG/PcrG family of T3SS chaperone proteins is partially folded.  The conformational dynamics 
perhaps contribute to their functional versatility, which is a characteristic signature of many 
flexible proteins.  Overall, the LcrG/PcrG family of proteins can be added to a growing list of 
partially folded proteins that play important roles in the bacterial type III secretion systems.  The 
NMR titration data indicate that the tip proteins induce a global change in the overall structure of 
the chaperones upon complex formation.  Further, the C-terminus of LcrG (Ser-52 to Ile-67) was 
identified to be important in blocking the secretion of Yop effectors in the Y. pestis T3SS. 
Also described here is a crystal structure of LcrV, at a higher resolution (1.65 Å) than the 
previously described structure 1R6F.  This current structure contains native residues in the N-
terminal domain of LcrV as opposed to the original crystal structure, 1R6F, which was solved 
using triple mutations (K40A/D41A/K42A) in the N-terminal domain.  The current structure 
should prove useful in future studies of the LcrV-translocon interaction.    
The work presented in this dissertation provides the first structural insight into the conformation 
and dynamics of the LcrG/PcrG family of chaperones in solution and upon complex formation.  
This has enhanced our understanding of the mechanism by which these chaperones perform their 
multiple roles in regulating the type III secretion system. 
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CHAPTER 1: Introduction 
A key step involved in the pathogenesis of many bacteria is the secretion of virulence factors 
from the bacterial cytoplasm into the host cell.  Accordingly, a number of complex protein 
translocation systems have evolved to aid the secretion process.  Among them, the type III 
secretion system (T3SS) is utilized by many pathogenic Gram-negative bacteria to deliver 
effector proteins into the cytosol of targeted host cells (1).  In this dissertation, the T3SS of two 
model organisms, Yersinia pestis and Pseudomonas aeruginosa, are chosen for structural studies 
of tip proteins (LcrV/PcrV) and their chaperones (LcrG/PcrG).  
1.1 Yersinia pestis, etiological agent of plague 
The Gram-negative bacterium Yersinia pestis is the causative agent of plague, a widespread 
zoonotic disease.  The three main plague pandemics have caused large-scale social devastation in 
the past, claiming over 200 million deaths worldwide (2).  Although it is not a major public 
health problem in the modern era, there are annual outbreaks of plague that occur throughout the 
world with ~2000-3000 (3) reported cases each year and it is considered a potential agent of 
bioterrorism (4).  Rodents and fleas are the primary carriers of Y. pestis.  Following the bite of an 
infected rat flea, Y. pestis multiplies in the lymph node causing bubonic plague.  The infection 
can then spread into the bloodstream causing septicemic plague, and finally aerosol transmission 
of the bacteria by infected individuals causes pneumonic plague (5).  Although bubonic plague 
can be successfully treated with antibiotics, pneumonic plague is almost invariably fatal (4, 5).  
The rapid development of pneumonic plague has made effective treatments with antibiotics 
difficult (4, 5). 
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1.2 Pseudomonas aeruginosa, an opportunistic pathogen 
Pseudomonas aeruginosa is a ubiquitous Gram-negative pathogen and is capable of colonizing 
and infecting a large number of mammalian tissues (6).  It is an opportunistic pathogen and is a 
common cause of nosocomial infections in immuno-compromised patients.  It is commonly 
associated with patients suffering from sepsis, cystic fibrosis, pneumonia, urinary tract 
infections, wounds, and burns (6, 7).  Despite treatment with potent antibiotics, the mortality rate 
is approximately 40% in cases of acute infections (7).  The growing number of multi-drug 
resistant isolates of P. aeruginosa is a major concern for public health. 
1.3 The Type III Secretion System 
Both Y. pestis and P. aeruginosa harbor a contact-mediated protein-export apparatus, the T3SS, 
which is also referred to as an injectisome.  The T3SS plays a key role in their pathogenesis and 
allows these bacteria to inject virulence proteins directly into the eukaryotic cells to initiate 
infection (1, 8, 9).  The T3SS has been identified in plant, animal, and insect pathogens (1, 8, 9).  
Among these are many Gram-negative bacteria including Salmonella, Shigella, Yersinia, 
Pseudomonas, Burkholderia, Escherichia and Chlamydia spp.  The T3SS present in these animal 
pathogens can be grouped into three families, (i) the Ysc- family of T3SS includes the Yersinia 
Ysc, the Pseudomonas Psc, and the Aeromonas Asc, (ii) the Inv-Mxi-Spa family includes the 
Salmonella (Salmonella Pathogenicity Island-1 i.e. SPI-1) and Shigella systems, and (iii) the Ssa-
Esc family includes the Salmonella (Salmonella Pathogenicity Island-2 i.e. SPI-2), 
enteropathogenic E. coli (EPEC) and the enterohemorrhagic E. coli (EHEC) systems (10).  The 
Ysc-family of T3SS is the focus in this dissertation. 
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 About 25 different proteins are required for the proper functioning of the T3SS, which is 
composed of both structural and non-structural proteins (1).  The structural proteins are needed 
to assemble the needle apparatus, which consists of a membrane embedded basal structure, an 
external needle that protrudes from the bacterial surface, and a tip complex that caps the needle.  
Upon host cell contact, a translocon is assembled between the needle tip complex and the host 
cell, serving as a gateway for translocation of effector proteins by creating a pore in the host cell 
membrane.  Following delivery into the host cytoplasm, effectors initiate and maintain infection 
by manipulating host cell biology, such as cell signaling, intracellular trafficking, cytoskeletal 
dynamics, inflammatory response, and inhibition of phagocytosis.  Finally, chaperones play an 
important role in the assembly, function and regulation of the different T3SS components, 
namely the effectors, translocon, needle and tip proteins (1).  
1.4 The Type III Secretion System in Yersinia pestis 
In Y. pestis the genes for the T3SS, which is also referred to as the Ysc-Yop system, is encoded 
on a 70-kb plasmid called pCD1 (8, 9, 11).  The T3SS allows Y. pestis to inject effector Yops 
(Yersinia outer proteins) into the cytosol of eukaryotic cells (Figure 1-1).  The six known 
effector Yops (YopH, T, E, O, P/J, and M) then collectively act towards disturbing the dynamics 
of the cytoskeleton, preventing phagocytosis and blocking the production of pro-inflammatory 
cytokines, adhesion molecules and chemokines; thereby favoring the survival and multiplication 
of Y. pestis inside the host cells (8, 9).  The needle apparatus consists of a basal body that spans 
the peptidoglycan layer and the two bacterial membranes.  The basal body is composed of an 
outer membrane (OM) ring formed by the secretin protein YscC, an inner membrane (IM) ring 
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formed by two proteins, YscD and YscJ, an export apparatus composed of five different proteins 
YscV, U, R, T and S and an ATPase, YscN (12).  The external part of the Ysc needle apparatus 
is made up of a hollow needle with a diameter of ~20 Å (8).  The needle is formed by the helical 
polymerization of a small protein, YscF (8).  On the distal end of the needle sits the tip complex 
formed by several copies of the tip protein, LcrV (8, 13).  Upon host cell contact, two 
hydrophobic proteins, YopB and YopD, assemble the translocon, which forms a pore in the host 
cell membrane to allow the passage of effectors inside the host cells (8).  LcrV, YopB and YopD 
are indispensable for the delivery of the effectors into the host cell (8).  Several of these Yops 
need the assistance of specialized chaperones for their efficient secretion through the injectisome 
(8).  Likewise, while inside the bacterial cytosol, the tip protein LcrV is chaperoned by a smaller 
protein, LcrG (95 residues).  Analysis of these two proteins, LcrV and LcrG, forms an integral 
part of my dissertation.  
1.5 The Type III Secretion System in Pseudomonas aeruginosa 
The T3SS in P. aeruginosa is encoded by ~36 chromosomal genes present in five operons, 
together with 6 other genes scattered throughout the chromosome (14).  The overall architecture 
of the T3SS in P. aeruginosa is similar to the Ysc-Yop system in Y. pestis (Figure 1-1).  Similar 
to the Yersinia system, the base is composed of an OM ring formed by the secretin PscC, and an 
IM ring formed by the lipoprotein, PscJ (14).  The ATPase, PscN, energizes the export of 
substrates through the secretion channel (14).  Likewise the external needle is composed of PscF,  
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Figure 1-1.  Schematic of the T3SS of Y. pestis and P. aeruginosa.  The names of the respective 
proteins that assemble the different parts of the T3SS are colored in blue for Y. pestis and green 
for P. aeruginosa.  The base spans the bacterial outer (OM) and inner membrane (IM).  The 
needle is formed by the polymerization of YscF/PscF.  LcrV/PcrV forms the pentameric V-tip 
complex that sits on top of the needle.  YopB, YopD/PopB, PopD assemble the translocon.  An 
effector protein (blue ribbon) is transferred through the T3SS and delivered to the host cells.  
LcrG and PcrG function as chaperones of the respective tip proteins LcrV and PcrV.  This figure 
is modified from (15). 
6 
 
the tip complex is formed by PcrV, and the hydrophobic proteins PopB and PopD assemble to 
form the translocon (14).  Upon assembly of the T3SS, P. aeruginosa utilizes this system to 
inject effector proteins into the host cell.  The four known effector proteins (ExoS, T, U and Y) 
then disrupt the epithelial barrier, inhibit wound repair, induce apoptosis and prevent bacterial 
uptake by phagocytes (7).  Similar to Yersinia, chaperones play an important role in assisting 
effectors, needle protein, translocon protein and the tip protein (14).  The tip protein of P. 
aeruginosa T3SS, PcrV is chaperoned by a small protein, PcrG (98 amino acids) (16, 17).  
Analysis of the structure and function of these two proteins PcrV and PcrG forms an integral part 
of my dissertation.   
1.6 V-tip proteins, roles, structure and assembly 
The Yersinia LcrV and the Pseudomonas PcrV belong to the same T3SS family and can be 
grouped together as V-tip proteins (1, 10, 15).  LcrV and PcrV share ~37% sequence identity 
with each other (15).  The tip proteins play an important role in the pathogenicity of Y. pestis and 
P. aeruginosa.  Deletion mutants of the genes encoding the tip proteins, LcrV or PcrV were 
avirulent in mice (15, 18-22) and non-cytotoxic during infection of cultured epithelial or 
phagocytic cells (17, 23-25).  The tip proteins have multifunctional roles.  Firstly, due to their 
extracellular localization, they function as host cell sensors (10, 15, 17, 26).  Secondly, they 
serve as a platform for the assembly of the translocon (23, 25, 27).  LcrV and PcrV help in the 
proper insertion of the translocon proteins YopB/YopD and PopB/PopD, respectively in the host 
cell membranes, and thereby assist in the formation of functional pore complexes (23, 25, 27).  
Thirdly, they are important for the translocation of effector proteins into the host cytosol (10, 17, 
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24, 27, 28) and they also regulate the secretion of effectors into the host cell (10, 15, 17, 26).  
This mechanism of regulation of effector secretion is different between PcrV and LcrV and will 
be discussed in the following sections. 
The 2.2 Å crystal structure of LcrV (29) represents what is currently known about the atomic 
structure of the LcrV/PcrV family of tip proteins (Figure 1-2).  This crystal structure was solved 
using an LcrV construct containing triple mutations (K40A/D41A/K42A) (29).  The overall 
structure of LcrV can be described as “dumbbell-shaped” consisting of a central coiled coil 
connected by two globular domains (29).  The central coiled coil motif of LcrV is a distinct 
structural feature that is highly conserved among all the known tip protein structures like SipD 
(Salmonella) (30, 31), BipD (Burkholderia) (32, 33) and IpaD (Shigella) (32).  Comparisons of 
these tip protein structures, however, point to the absence of an N-terminal α-helical hairpin in 
LcrV.  The N-terminal α-helical hairpin folds independently in SipD and IpaD (34, 35) and 
functions as a self-chaperone by preventing the self-oligomerization of BipD and IpaD (32).  
Additionally, the N-terminal α-helical hairpin hinders the interaction between the needle 
protomer PrgI and the tip protein SipD (31).  Due to the absence of this N-terminal α-helical 
hairpin in LcrV, it is suggested that a small cytoplasmic protein, LcrG that functions as the 
chaperone for LcrV adopts a similar α-helical hairpin structure (26, 32).  Likewise, the LcrG 
homolog in Pseudomonas, PcrG functions as a chaperone for the PcrV tip protein and is 
hypothesized to adopt an α-helical hairpin structure.  The absence of an intra-molecular 
chaperoning domain in LcrV and PcrV hints at divergent assembly processes at the needle tip 
between the Salmonella/Shigella and the Yersinia/Pseudomonas species. 
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Low resolution electron micrographs of the Yersinia LcrV tip were obtained by Mueller et al. 
(13), where they visualized LcrV as a well-defined structure at the tip of the needle (Figure 1-2).  
Interestingly, both pcrV (Pseudomonas) and acrV (Aeromonas) could successfully complement 
an lcrV deletion by forming tip structures on Yersinia needles (13).  This highlighted the 
structural and functional conservation among members of the V-tip protein family.  The structure 
of the Yersinia LcrV tip complex showed a distinct head, neck, and a base (13).  Broz et al. (27) 
concluded that the LcrV N-terminal globular domain forms the base, the C- terminal globular 
domain forms the head, and the coiled coil region forms the neck.  The base was also shown to 
be responsible for the correct insertion of the Yersinia translocon protein YopB into the host cell 
membrane (27).  Broz et al. (27), used the low-resolution structural data from the scanning 
transmission electron microscopy (STEM) (13) and multiple copies of the LcrV crystal structure 
(29) to fit the low-resolution density map to obtain a model of the tip complex.  In the model of 
Broz et al. (27) LcrV is oriented where the N and C-termini point towards the needle, while the 
coiled coil domain is oriented inwards.  Five LcrV monomers were found to be the best fit in this 
model.  Broz et al. concluded that the Yersinia tip complex is formed by an LcrV pentameric 
ring (27). 
1.7 Chaperones of the tip proteins 
The architecture of the N-terminal domain of the V-tip proteins is different from other tip 
proteins of the T3SS families.  Significantly, the V-tip proteins do not have any intra-molecular 
self-chaperoning domain (15, 26).  It is suggested that two other relatively smaller cytoplasmic 
proteins, LcrG (95 amino acids) and PcrG (98 amino acids), serve as cognate chaperones for the 
9 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 1-2.  (A) Crystal structure of LcrV (29).  The globular N-terminal domain is colored red, 
the central coiled coil is colored gray, and the mixed α/β domain is colored green.  Scanning 
transmission electronmicrographs (STEM) showing (B) LcrV forms a well-defined structure 
(white arrow) at the tip of the needle.  (C) the three distinct parts (head, neck and base) formed 
by the LcrV tip complex.  (D) typical single images of the tip complexes formed by LcrV.  
Figures B, C and D are taken from (13). 
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V-tip proteins LcrV and PcrV, respectively (15,17, 26).  LcrG and PcrG share about 40% 
sequence identity with each other (16).  The chaperones and the V-tip proteins are all part of the 
same operon (10, 17).  LcrG and PcrG are referred to as export chaperones and they facilitate the 
secretion of their respective tip proteins (17, 36).  An lcrG deletion leads to significant decrease 
in LcrV secretion, which is restored upon complementation with wild type lcrG (36).  
Additionally, an LcrG mutant (A16R) that has lost the capacity to bind LcrV led to defective 
LcrV secretion (17, 37).  Similarly both deletion of pcrG and a PcrG mutant (V16R) that can no 
longer bind to PcrV, led to a significant defect in PcrV export (17).  
Other than facilitating secretion of the V-tip proteins, the LcrG/PcrG chaperones have additional 
regulatory roles in the T3SS of Y. pestis and P. aeruginosa.  LcrG functions as a negative 
regulator of Yop secretion, i.e. increased levels of LcrG results in blockage of Yop secretion (37-
41).  LcrG also plays a facilitative role in targeting both effector Yops and translocator Yops 
(YopD) into the host cells (36, 42).  LcrG does not have a direct role in targeting of Yops, rather 
it is an indirect effect of facilitating the secretion of LcrV, which then acts as the assembly 
platform for the translocator Yops, thereby allowing the secretion of Yop effectors.  Like LcrG, 
PcrG acts as negative regulator of effector secretion and assists in the translocation of effectors 
into the host cells (17, 43). 
1.8 Regulation of Yop secretion by LcrG and LcrV  
In Y. pestis, the 70kb plasmid that encodes the T3SS is also called the low-Ca+2 response (LCR) 
virulence plasmid (2, 11, 37, 41, 44).  In vitro, millimolar concentrations of Ca+2 maintain basal 
level of expression and almost no secretion of Yops (37, 41, 44).  Removal of Ca+2 leads to full 
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induction of expression and secretion of Yops (37, 41, 44).  Due to the dependence of Yersinia 
T3SS on Ca+2, this regulatory mechanism is designated as the LCR.  The absence of Ca+2 
provides an unidentified signal that mimics the presence of host cell contact, which leads to the 
induction of LCR (41). 
The secretion of Yops by the Y. pestis T3SS is a highly regulated process, and Yops are secreted 
in vivo only upon contact with the host cells (45).  Several proteins are involved in regulating 
Yop secretion, among which, LcrG and LcrV play important roles in this process.  The current 
model that explains the regulation of Yop secretion by LcrG and LcrV is the “Titration” model 
(Figure 1-3) proposed by Nilles and coworkers (37, 39, 41).  In this model, the absence of host 
cell contact or in the presence of Ca+2, LcrG blocks the T3SS from the cytoplasmic face and 
prevents secretion of Yops (Figure 1-3).  Upon host cell contact or in the absence of Ca+2, there 
is an upregulation of the expression of LcrV, which then titrates away LcrG by forming a stable 
LcrG-LcrV complex (Figure 1-3).  This relieves the negative block thereby allowing the 
secretion of Yops.  Thus, LcrV controls secretion of effectors from the cytoplasm through its 
interaction with LcrG.  Hence, if LcrG-LcrV interaction is blocked, LcrG cannot be titrated away 
from the T3SS resulting in a constitutive blockage of secretion of Yops regardless of host cell 
contact or Ca+2  concentration (Figure 1-3). 
1.9 Regulation of effector secretion by PcrG and PcrV  
As in Y. pestis, removal of Ca+2 in vitro, or the presence of host cell contact can trigger the 
secretion of effectors by the P. aeruginosa T3SS (43, 46, 47).  The regulation of effector 
secretion by PcrG and PcrV are not well characterized as compared to the Yersinia counterparts.   
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Figure 1-3.  The LcrG titration model.  (A) In the presence of millimolar amounts of Ca+2, the 
Ysc is blocked by LcrG from the cytoplasm, and two other proteins YopN and TyeA from the 
cell surface.  This secretion block retains LcrQ, a negative regulator, in the cell resulting in the 
repression of LCR regulated genes.  (B) Upon host cell contact, LcrQ is released and higher 
levels of LcrV are produced.  (C) Due to higher levels of LcrV, it titrates away LcrG from the 
Ysc by forming a stable LcrG-LcrV complex.  This removes the negative block thereby allowing 
the Yops to be secreted into the host cells.  (D) If the LcrG-LcrV interaction is blocked, then 
LcrG cannot be titrated away from the Ysc, thereby blocking secretion of Yops.  This figure is 
taken from (37). 
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Deletion of pcrG and pcrV led to upregulation of effector export (17, 46), and both these 
deletions had an additive effect on secretion of effectors (17).  Lee and coworkers (17) proposed 
a model that explains the regulation of effector secretion by PcrG and PcrV (Figure 1-4).  
According to this model, the export of PcrV and its assembly at the needle tip, together with the 
interaction of PcrG with an unknown cytoplasmic component of the T3SS, turns off the secretion 
of effectors (Figure 1-4).  However, host cell contact induces a conformational change in the 
needle tip, which is propagated to the base of the apparatus, thereby releasing PcrG and 
triggering the secretion of effectors (Figure 1-4).  Thus, unlike the Yersinia model, where LcrV 
controls the secretion of effectors from the cytoplasm, PcrV controls the secretion of effectors by 
assembling at the needle tip.  But similat to Yersinia LcrG, Pseudomonas PcrG also controls 
secretion of effectors from the cytoplasm.  However, a PcrG point mutant (V16R) that was 
incapable of binding to PcrV, could control the secretion of effectors (17).  Contrastingly, an 
LcrG mutant (A16R) that was unable to bind to LcrV, constitutively blocked the secretion of 
Yop effectors (37).  Hence, contrary to the Yersinia model, where the LcrG-LcrV complex is 
important in the regulation of effector secretion, the PcrG-PcrV complex is suggested to be not 
important for regulation of effector secretion by the P. aeruginosa T3SS (17).  Thus, unlike 
LcrG, PcrG controls secretion of effectors in a PcrV independent manner.  
1.10 Biophysical properties of the chaperones and the chaperone-tip complexes 
Knowledge about the three-dimensional structure of the chaperones or the chaperone-tip 
complexes is scant.  Results from Circular Dichroism (CD) have shown that LcrG and PcrG are 
α-helical proteins (16, 48).  Nanao et al. (16) has reported that the α-helicity of PcrG increases 
while in complex with PcrV, indicating that the structure of PcrG is somewhat stabilized upon  
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Figure 1-4.  (A) The export of PcrV (red) and its assembly at the needle tip, together with 
interaction of PcrG (blue) with an unknown cytoplasmic component (X shown in yellow) of the 
T3SS, turns off secretion of effectors.  (B) Host cell contact induces a conformational change in 
the needle tip, which is propagated to the base of the apparatus thereby releasing PcrG and 
triggering secretion of effectors.  This figure is modified from (17). 
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complex formation with PcrV (16).  Temperature scanning CD measurements showed that PcrG 
unfolds in a non-cooperative manner without a clear melting temperature (16).  Based on the 
coiled coil nature of the self-chaperoning domains of IpaD, BipD and SipD; the helical nature of 
LcrG and PcrG; and the computational prediction (COILS Algorithim predicted that Asp-7 to 
Ala-35 of LcrG forms a coiled coil) (40, 48), it has been suggested in the literature that LcrG and 
PcrG form a coiled coil structure (26).  Further, others have proposed that the interaction 
between the V-tip proteins (LcrV/PcrV) and their chaperones (LcrG/PcrG) are mediated by 
coiled coil domains (40, 48). 
A direct interaction between LcrG and LcrV has been previously demonstrated by yeast-two-
hybrid assay (40), chemical cross-linking and co-purification studies (39), surface plasmon 
resonance (SPR) (48), and ELISA (48).  Using yeast-two-hybrid assay, it was demonstrated that 
the N-terminal region of LcrG is involved in the protein-protein interaction with residues Asp-7 
to Thr-40 being the minimal region of LcrG required for binding to LcrV (Figure 1-5) (40).  The 
coiled coil domain of LcrV was identified to be the site of protein-protein interaction with LcrG 
(48, 49).  The dissociation constant (Kd) of the LcrG-LcrV interaction was estimated to be ~140 
nM, which was determined by SPR (48).  On the other hand, for the PcrG-PcrV complex, Kd of 
binding was estimated to be ~15.6 nM using SPR (16).  Lee et al. (17) provided the first 
evidence using pull down and effector export assay that the two separate functions of PcrG, 
namely, the regulation of effector secretion and binding to its cognate tip protein, can be 
assigned to the two distinct halves of PcrG.  The N-terminus of PcrG was demonstrated to be 
critical for binding PcrV, while the C-terminus was responsible for regulation of effector 
secretion, but both the halves of PcrG were required for efficient export of PcrV (Figure 1-5)  
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Figure 1-5.  (A) Linear representation of PcrG showing the PcrV-binding region (red), the 
secretion regulation region (green), and the PcrV-export region (blue).  (B) Linear representation 
of LcrG showing the LcrV-binding region (red) and the residue important for regulation of 
secretion (green).  “N” and “C” denote the N and C termini of the two proteins.
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(17).  However, there was no evidence showing that the C-terminus of LcrG is important for the 
regulation of Yop secretion, while preliminary data suggests that Phe-48 in LcrG might be 
important for this regulatory function (Figure 1-5) (40). 
1.11 Conclusion 
There is a dearth of structural knowledge about the chaperones and the chaperone-tip complexes 
of the V-tip protein family.  Specifically, critical questions remain unanswered, among them: i) 
The structure of V-tip chaperones, LcrG and PcrG; ii) The atomic-level detail of LcrG-LcrV and 
PcrG-PcrV interactions including the key residues involved in complex formation; and iii) 
Structural aspects of LcrG and PcrG which help them achieve their functional versatility. 
Accordingly, the primary aim of this research was to determine the three-dimensional structures 
of LcrG and PcrG and to characterize their interactions with their cognate tip proteins LcrV and 
PcrV by NMR spectroscopy.  The subsequent chapters in this dissertation include, NMR 
characterization of the structure and dynamics of the V-tip chaperones and their complex: LcrG 
(Chapter 4), PcrG (Chapter 6), the LcrG-LcrV complex (Chapter 5) and the PcrG-PcrV complex 
(Chapter 6).  The crystal structure of LcrV without the triple mutations in the N-terminal domain 
and at a higher resolution of 1.65 Å is also reported (Chapter 3).  The N-terminal domain of 
LcrV was suggested to be the site of protein-protein interaction with the translocon (27), and 
hence this current structure of LcrV reported here will be useful.  
Overall, the research in this dissertation has contributed new knowledge towards understanding 
the structural behavior of V-tip chaperones and how they interact with their respective V-tip 
proteins.  The knowledge gained about their structures sheds light on their functional versatility.  
18 
 
In addition, this research has provided a refined crystal structure of LcrV with native residues in 
the N-terminal domain that will be useful in future structural studies of the protein-protein 
interaction of LcrV.  
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CHAPTER 2: Materials and Methods 
2.1 Subcloning, Protein Expression, and Purification 
2.1.1 LcrG constructs  
DNA fragments encoding full-length LcrG, (residues 1-95; henceforth referred to as LcrGFL) and 
truncated LcrG (residues 7-73; henceforth referred to as LcrG7-73) were PCR amplified from the 
Yersinia pestis plasmid pCD1 (1) and subcloned into a pET-21a vector (Novagen) using NdeI 
and BamHI as the restriction sites.  The vector was modified to encode an N-terminal His6-
tagged GB1 domain followed by a tobacco etch virus (TEV) protease site.  GB1 (56 residues) is 
the B1 immunoglobulin binding domain from Streptococcus protein G that functions as a 
solubility enhancement tag (2, 3), and a GB1 expression plasmid (obtained from Peter E. Wright, 
Scripps Research Institute, La Jolla, California) was used for subcloning.  The TEV protease site 
allows the cleavage of the target protein from the His6-GB1 tag.  For protein expression, the 
expression plasmids were transformed in E. coli BL21 (DE3) DNAY cells.  The gene product of 
E. coli dnaY is an arginine tRNA corresponding to a rare arginine codon, thereby allowing the 
overproduction of this rare tRNA product.  The freshly transformed colonies were used to 
inoculate a 50 mL LB overnight starter culture at 37 °C using 30 µg/mL kanamycin and 100 
µg/mL carbenicillin as antibiotics.  Isotopically 15N-labeled proteins were obtained by using the 
cell pellet from the overnight growth as the inoculum in a 1 L M9 minimal media supplemented 
with 1 g/L of 15N-ammonium chloride (Isotec).  Cells were grown at 37 °C until A600 was ~0.6 to 
0.8, induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG), and cell growth was 
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continued at 15 °C overnight in a shaker-incubator (to a final A600 ~2.0).  The cells were diluted 
to obtain this A600 reading.  Cells were harvested by centrifugation at 4,000 rpm (using the 
centrifuge Sorvall RC 5C Plus from Thermo Scientific) for 10 minutes and the pellet was 
resuspended in ~30 ml of binding buffer (500 mM NaCl, 20 mM Tris-HCl, 5 mM imidazole, pH 
8.0).  Cells were kept on ice, ~300 µl of 1 mM phenylmethylsulfonyl fluoride (PMSF) was 
added, and the cells were lysed by sonication using a Branson Digital Sonifier for 3 minutes of 2 
seconds long pulses at 80% power followed by 20 seconds gaps.  Cellular debris was removed 
by centrifugation of the cell lysate, and 600 µl of 5% polyethyleneimine (PEI) was added to the 
supernatant to precipitate the nucleic acids.  The mixture was centrifuged at 13,000 rpm (using 
the centrifuge Sorvall RC 5C Plus from Thermo Scientific) for 10 minutes, and the supernatant 
was loaded onto a pre-charged Ni+2 affinity column, which was equilibrated with ~35 ml of 
binding buffer.  The column was washed with ~100 ml of binding buffer, and the fusion protein 
was eluted using ~60 ml of elution buffer (500 mM NaCl, 20 mM Tris, 250 mM imidazole, pH 
8.0).  The fusion protein was then digested by placing the protein in a dialysis tubing with 250 µl 
of 0.06 mM recombinant Tobacco Etch Virus (TEV) protease (4), and the dialysis tubing was 
placed in 1 L of TEV buffer (50 mM Tris-HCl, 20 mM NaCl, 1 mM DTT, 0. 5 mM EDTA, pH 
8.0) overnight at room temperature.  The digested protein mixture was dialyzed again in 1 L 
binding buffer and passed through a second Ni+2 affinity column.  Recombinant LcrGFL/LcrG7-73 
were in the flow-through and column wash while the GB1 fusion tag was retained in the column.  
Recombinant LcrGFL and LcrG7-73 contained a three residue (GHM) N-terminal cloning artifact 
after TEV cleavage.  Recombinant proteins were concentrated using Amnicon Ultra 3K 
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(Milipore) and protein concentration was determined by absorbance at A280 using a Nanodrop 
(Thermo Fischer). 
Site-directed mutants (LcrG7-73 C34S, LcrG7-73 C34A and LcrGFL C34S) were generated by the 
Stratagene QuickChange Kit and confirmed by DNA sequencing.  All the LcrG mutants were 
expressed and purified by nickel affinity chromatography as described above.  Unlabeled 
proteins were expressed by using the overnight LB starter growth to inoculate a 1 L LB medium.  
LcrG7-73 C34S and LcrGFL C34S were also purified as 15N/13C double-labeled proteins by 
growing the cells in 1 L M9 minimal media supplemented with 1 g/L of 15N-ammonium chloride 
and 2.0 g/L 13C D-glucose.  In this dissertation, “labeled” proteins refer to isotopically labeled 
proteins unless otherwise mentioned.  Nine point mutants (I56N, K57E, K57L, R61E, R61L, 
I67N, K68E, K68L and L63N) and five deletion mutants (Δ52-57, Δ58-62, Δ63-67, Δ68-73, 
Δ52-73) of the LcrG 52-73 region (details of the mutants can be found in chapter 5) were 
generated by the Stratagene QuickChange Kit in pBAD vector for the Yersinia Yop secretion 
assay. 
2.1.2 LcrV construct  
In the crystal structure of LcrV determined by Derewenda et al. (5), the extreme N and C-
terminal residues of LcrV (residues 23-27 and 323-326) lacked electron density and therefore 
were disordered.  Therefore, a truncated LcrV spanning residues 28-322 was subcloned for 
protein expression.  DNA fragment encoding LcrV residues 28-322 was PCR amplified from the 
Y. pestis plasmid pCD1 (1) and subcloned into a modified pET-21a vector as described in section 
2.1.1.  The C273S point mutation was introduced in the LcrV construct by the Stratagene 
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QuickChange Kit and confirmed by DNA sequencing.  Hence the LcrV construct generated was 
LcrV28-322 C273S.  Since there is only one LcrV construct used, LcrV28-322 C273S will be 
referred to as LcrV throughout this dissertation.  Derewenda et al. (5) also introduced a C273S 
point mutation in LcrV to prevent the dimerization of LcrV and to improve the purification of 
recombinant LcrV.  LcrV was expressed and purified by nickel affinity chromatography as 
described in section 2.1.1. 
2.1.3 PcrG constructs  
DNA fragments encoding full-length PcrG (residues 1-98; henceforth referred to as PcrGFL) and 
truncated PcrG (residues 9-76; henceforth referred to as PcrG9-76) were PCR amplified from the 
P. aeruginosa pAO1 strain and subcloned into a pET-21a vector at the NdeI and BamHI sites.  
For PcrG, the expression vector was modified to encode a C-terminal fusion tag consisting of a 
TEV protease site, the GB1 domain, and a hexahistidine tag.  PcrGFL and PcrG9-76 were 
expressed and purified by nickel affinity chromatography as described in section 2.1.1. Cleavage 
with TEV protease resulted in a C-terminal cloning artifact (GSENLYFQ) in PcrGFL and PcrG9-
76.  PcrG9-76 was also expressed and purified as 15N/13C double labeled protein. 
2.1.4 PcrV construct  
P. aeruginosa PcrV residues 25-294 (henceforth referred to as PcrV25-294 ) was subcloned from 
the Pseudomonas pAO1 strain in the same manner as described for the LcrG and LcrV 
constructs.  The N-terminal 24 residues of PcrV were truncated based on sequence similarity to 
the disordered N-terminal region in the crystal structure of its homologue, LcrV (5).  Since there 
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is only one PcrV construct used, PcrV25-294 will be referred to as PcrV throughout this 
dissertation.  Recombinant PcrV was expressed and purified by nickel affinity chromatography 
as described in section 2.1.1. 
2.1.5 13C-ILV labeling of LcrG7-73 C34S, PcrG9-76 and LcrV  
The methyl groups of Ile, Leu and Val were 13C labeled by overexpression of LcrG7-73 C34S, 
PcrG9-76 and LcrV in E. coli minimal media supplemented with 2-ketobutyric acid-4-13C sodium 
salt hydrate (Isotec, # 571342) and 2-keto-3-(methyl-13C)-butyric acid-4-13C sodium salt (Isotec 
# 571334) following published protocols (6).  The 2-ketobutyric acid-4-13C sodium salt hydrate 
is the precursor for Ile, and it labels the δ methyl group of Ile.  The 2-keto-3-(methyl-13C)-butyric 
acid-4-13C sodium salt is the precursor for Leu and Val, and it labels the γ1 and γ2 methyl groups 
of Leu and Val.  Cells were grown at 37 °C and supplemented with 100 mgs of the keto acids 
(sterilized by filtration through 0.2 µm syringe filter after dissolving in sterile water) when A600 
reached ~0.4-0.5.  At A600 ~0.6-0.8 or about 45-60 minutes after addition of the keto acids, 
protein expression was induced with 1 mM IPTG and cell growth was continued overnight in a 
15 °C shaker-incubator.  Cells were harvested and recombinant proteins were purified by nickel 
affinity chromatography as described in section 2.1.1.  Point mutants of Ile, Leu and Val residues 
of LcrG7-73 C34S, PcrG9-76 and LcrV (details of the mutants can be found in chapters 5 and 7) 
were generated by the Stratagene QuickChange Kit and expressed and purified in the same way 
as discussed in section 2.1.1. 
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2.1.6 15N amino acid specific labeling of LcrG7-73 C34S  
The backbone amides of Ile and Phe of LcrG7-73 C34S were specifically labeled with 15N-Ile and 
15N-Phe to generate 15N-Ile-LcrG7-73 C34S and 15N-Phe-LcrG7-73 C34S respectively.  Freshly 
transformed E. coli BL21 (DE3) DNAY cells expressing LcrG7-73 C34S were grown overnight in 
a 1 L LB-broth at 37 °C with shaking.  The overnight cell growth was centrifuged and the cell 
pellet was resuspended in two flasks containing 500 ml M9 minimal media supplemented with 
125 mg/L of the specific 15N-labeled amino acid, 450 mg/L of unlabeled Val, Leu (for 15N-Ile) or 
450 mg/L of unlabeled Tyr, Trp, Ala, Ser, Gly, Cys (for 15N-Phe) and 300 mg/L of the remaining 
unlabeled amino acids till an A600 ~0.6 was reached.  Cells were incubated with shaking at 37 °C 
for ~20 minutes until the A600 reached ~0.8.  Protein expression was induced with 1 mM IPTG.  
Cell growth was continued at 37 °C for ~4 hrs until the A600 was ~2.5.  Cells were diluted to 
obtain this A600 reading.  Cells were harvested by centrifugation and the selectively amino acid 
labeled recombinant proteins were purified as described in section 2.1.1. 
2.2 Circular Dichroism (CD) Spectroscopy and Thermal Denaturation  
Typically CD spectra were acquired in triplicate using 1-2 µM of protein samples in buffer (10 
mM sodium phosphate pH 7.0, 10 mM NaCl).  CD spectra were acquired from 190 to 260 nm at 
20 °C with a scan rate of 50 nm/minute using a JASCO J-815 Spectropolarimeter.  Thermal 
denaturation curves were monitored by measuring the molar ellipticity at 222 nm by 
progressively heating the protein from 20 °C to ~80-100 °C at a temperature ramp rate of 2 
°C/minute.  CD values in ellipticity (mdeg) were converted to molar ellipticity θ (degcm2 × 
dmole-1) by using the formula θ = {mdeg × 100} / {concentration (mM) × 105}.  The melting 
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temperature (Tm) of LcrV was determined by using the JASCO software.  The CD spectra for the 
PcrG constructs were acquired by Bryce Nordhues (7). 
2.3 Nuclear Magnetic Resonance (NMR) Spectroscopy 
2.3.1 Two dimensional 1H-15N HSQC spectra of LcrG and PcrG constructs. 
NMR data were acquired at 25 °C using a Bruker Avance 800 MHz spectrometer equipped with 
a cryogenic triple resonance probe.  All the NMR samples were dialyzed overnight in NMR 
buffer (10 mM sodium phosphate pH 7.0, 10 mM NaCl) and NMR samples contained 10% (v/v) 
D2O.  Initial 2D 1H-15N HSQC spectra (8) were acquired using 0.5 - 0.8 mM of protein samples 
for LcrGFL, LcrG7-73, LcrG7-73 C34S, LcrG7-73 C34A, LcrGFL C34S, PcrG9-76 and PcrGFL.  The 
2D 1H-15N HSQC spectrum of LcrGFL C34S was acquired using a Bruker Avance 600 MHz 
spectrometer.  Typical NMR acquisition parameters for the LcrG constructs were 16 scans, 23 
ppm 15N sweep width centered at 117.5 ppm, 2048 1H complex points, and 150 15N complex 
points.  The initial 2D 1H-15N HSQC spectra of PcrG were acquired by Bryce Nordhues (7).  All 
NMR data reported were processed with NMRPipe (9) and analyzed by NMRView (10). 
2.3.2 Two dimensional 1H-13C HSQC spectra of LcrG, PcrG and LcrV constructs  
NMR data were acquired at 25 °C using a Bruker Avance 600 MHz spectrometer equipped with 
an inverse triple resonance probe.  NMR samples contained 0.3 – 0.5 mM protein (LcrG7-73 
C34S, PcrG9-76, LcrV) and were used to acquire 2D 1H-13C HSQC spectra.  For the purpose of 
assignment of the methyl groups, this experiment was done on several Ile, Leu and Val mutants 
of the proteins mentioned above (details of the mutants can be found in Chapters 5 and 7).  
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Typical acquisition parameters used to acquire 1H13C HSQC for the LcrG and PcrG constructs 
were 52 scans, 15 ppm 13C sweep width centered at 16.3 ppm, 1024 1H complex points, and 200 
13C complex points.  For LcrV, the parameters were the same except for 32 scans and 18 ppm 
13C sweep width centered at 20 ppm. 
2.3.3 Backbone assignments of LcrG7-73 C34S, LcrGFL C34S, LcrG7-73 C34S-LcrV complex 
and PcrG9-76  
To acquire three dimensional (3D) NMR data for backbone assignments, 0.9 mM of 15N/13C 
LcrG7-73 C34S, 0.7 mM of 15N/13C PcrG9-76, 0.8 mM of 15N/13C LcrGFL C34S and 0.6 mM of 
15N/13C LcrG7-73 C34S-LcrV complex (1:1.2 ratio) were used for data collection.  The 3D NMR 
datasets HNCA, HNCACB and CBCA(CO)NH were acquired (11, 12).  Backbone assignments 
were obtained from 2D 1H-15N HSQC (8) and 3D HNCACB datasets.  For backbone assignment 
of LcrG7-73 C34S, we also used 15N specific amino acid labeling and mutational approach to 
assign the backbone resonances of a few amino acids that was difficult to assign from the 3D 
dataset (details can be found in chapter 4).  The secondary structures for LcrG7-73 C34S and 
PcrG9-76 were identified from the analysis of the Cα and Cβ chemical shifts (13, 14).  The 
random coil chemical shifts are obtained as described in (13).   
2.3.4 Heteronuclear {1H}- 15N NOE of LcrG7-73 C34S and PcrG9-76  
NMR samples containing 0.7 mM of 15N LcrG7-73 C34S or 15N PcrG9-76 in NMR buffer (10 mM 
sodium phosphate pH 7.0, 10 mM NaCl) were used to acquire the heteronuclear {1H}- 15N NOE 
datasets.  The heteronuclear {1H}- 15N NOE datasets were acquired as a pair of 2D datasets 
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collected in an interleaved manner as previously described (14) with 2048 (1H) × 128 (15N) 
complex points, 60 scans per point and 5 secs recycle delay.  The heteronuclear {1H}- 15N NOE 
was then calculated as the ratio of the intensities of each peak in the two 2D datasets.  Error bars 
were estimated from the standard deviation of the background signal of each spectrum.   
2.3.5 T1 and T2 relaxation experiment of LcrG7-73 C34S and PcrG9-76  
NMR samples containing 0.7 mM of 15N LcrG7-73 C34S or 15N PcrG9-76 were used to acquire the 
T1 and T2 backbone amide relaxation datasets.  The T1 and T2 relaxation were acquired as several 
separate 2D datasets with varying T1 (D7) and T2 (D20) delays as previously (15) described.  
The corresponding R1 and R2 values were determined by measuring the intensity decay for each 
peak as a function of the time delays.  The time delays used to determine the rate R1 were 10, 60, 
120, 240, 400, 900 and 1100 ms, and the time delays used to determine the rate R2 were 20, 40, 
50, 60, 70, 90, 100, 120 and 150 ms.  Peak intensities were obtained using NMRView (10) and 
fitted using GNUPLOT (16), and the deviations from fitting were reported as error bars. 
2.3.6 NMR titrations of 15N LcrG7-73 C34S with unlabeled LcrV and 15N PcrG9-76 with 
unlabeled PcrV 
For all the NMR titrations reported here, the binding partners were dialyzed together in the same 
NMR buffer.  NMR titrations were performed using 0.2 mM 15N LcrG7-73 C34S titrated with 
higher molar ratios (1:0, 1:0.5, 1:1.2, 1:2, 1:3, 1:4 and 1:6.5) of unlabeled LcrV.  Two 
dimensional (2D) 1H-15N HSQC (8) spectra were acquired for each titration point and spectra 
were superimposed to monitor the changes in the HSQC spectra of LcrG7-73 C34S upon complex 
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formation.  A 1:1.2 molar ratio for the 15N/13C LcrG7-73 C34S - LcrV was used to acquire the 3D 
NMR datasets.  This particular molar ratio was chosen, because it yielded the best signal to noise 
ratio.  Typical acquisition parameters used were 56 scans, 23 ppm 15N sweep width centered at 
117.5 ppm, 2048 1H complex points, and 200 15N complex points.  Titration experiments with 
0.1 mM of 15N LcrG7-73 were also done by addition of LcrV in molar ratios of 1:0 and 1:2 for 
comparison of the complexes formed by the wild type LcrG7-73 and the mutant LcrG7-73 C34S 
with LcrV.  The NMR titrations of 15N PcrG9-76 with unlabeled PcrV were acquired by Bryce 
Nordhues (7).  For NMR chemical shift mapping of the backbone, 2D 1H-15N HSQC spectra 
were acquired for 15N-PcrG9-76 titrated with increasing amounts of unlabeled PcrV.  Six samples 
were prepared in NMR buffer with 0.13 mM 15N-PcrG9-76 and varying PcrV concentration in 
molar ratios of 1:0, 1:0.25, 1:0.5, 1:1, 1:2 and 1:4.  
2.3.7 NMR titrations of 13C ILV-LcrG7-73 C34S with unlabeled LcrV  
NMR data were acquired at 25 °C using Bruker Avance 600 MHz spectrometer.  NMR chemical 
shift mapping of the methyl groups of Ile, Leu and Val of 13C ILV-LcrG7-73 C34S were 
performed by acquiring 2D 1H-13C HSQC spectra at 13C ILV-LcrG7-73 C34S: LcrV molar ratios 
of 1:0, 1:0.25, 1:0.5, 1:1 and 1:2.  The concentration of the labeled protein (13C ILV-LcrG7-73 
C34S) was kept at 0.36 mM.  The acquisition parameters used were 52 scans, 15 ppm 13C sweep 
width centered at 16.3 ppm, 1024 1H complex points, and 200 13C complex points. 
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2.3.8 NMR titrations of 13C ILV-PcrG9-76 with unlabeled PcrV  
NMR data were acquired at 25 °C using a Bruker Avance 600 MHz spectrometer.  NMR 
samples containing 0.3 mM 13C ILV-PcrG9-76 were titrated with unlabeled PcrV at molar ratios 
of 1:0, 1:0.25, 1:0.5, 1:1, 1:2 and 1:3. The acquisition parameters used were 52 scans, 15 ppm 
13C sweep width centered at 16.3 ppm, 1024 1H complex points, and 200 13C complex points. 
2.3.9 NMR titrations of 13C ILE-LcrV with unlabeled LcrG7-73 C34S or LcrGFL C34S  
NMR data were acquired at 25 °C using a Bruker Avance 600 MHz spectrometer. NMR samples 
containing 0.4 mM of LcrV were titrated with unlabeled LcrG7-73 C34S at molar ratios of 1:0, 
1:0.25, 1:0.5, 1:1, and 1:2.  The acquisition parameters used were 36 scans, 20 ppm 13C sweep 
width centered at 18 ppm, 1024 1H complex points, and 200 13C complex points.  Similar 
titrations were done using 0.4 mM of LcrV unlabeled LcrGFL C34S at molar ratios of 1:0, 1:0.25, 
1:0.5, 1:1, and 1:2.  
2.3.10 NMR titrations of 13C ILE-PcrV with unlabeled PcrG9-76 or PcrGFL  
13C ILV-PcrV (0.23 mM) was titrated with unlabeled PcrG9-76 dissolved in buffer (20 mM 
sodium phosphate pH 7.0, 20 mM NaCl, 10% D20).   Five molar ratios of 13C ILV-PcrV to 
PcrG9-76 of 1:0, 1:0.5, 1:1, 1:2, and 1:3 were used to acquire the 2D 1H-13C HSQC spectra at 30 
°C using a Bruker Avance 600 MHz spectrometer.  The acquisition parameters used were 56 
scans, 18 ppm 13C sweep width centered at 18 ppm, 1024 1H complex points, and 200 13C 
complex points.   
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Likewise, 0.13 mM of 13C ILV-PcrV was titrated with PcrGFL at 1:0, 1:0.5, 1:1, 1:2, and 1:3 
molar ratios and monitored by 2D 1H-13C HSQC with 80 scans, 18 ppm 13C sweep width 
centered at 18 ppm, 1024 1H complex points, and 200 13C complex points.  
2.4 Yersinia Yop secretion assay  
This work was done in collaboration with Dr. Gregory V. Plano (University of Miami, Florida).  
Y. pestis KIM5-3001 (parent), the lcrG deletion mutant (KIM5-3001.5, Δ39-53) and KIM5-
3001.5 carrying pBAD-LcrG or derivatives of this plasmid were cultured overnight at 27 °C in 
Thoroughly Modified Higuchi’s (TMH) medium.  Overnight cultures of each strain were used to 
inoculate 2 ml cultures of TMH alone or TMH containing 2.5 mM CaCl2 to an OD620 of 0.2. 
Protein expression was induced with 0.2% L-(+)- arabinose upon shifting the temperature from 
27 ºC to 37 ºC.  Fractions were collected after 5 hours incubation at 37 ºC.  Around 1 ml of each 
culture was harvested by centrifugation to separate whole bacterial cells (WC) from secreted 
proteins.  Trichloroacetic acid (TCA) was added to the culture supernatants (10% final 
concentration), incubated on ice overnight and precipitated proteins were collected by 
centrifugation.  WC and secreted proteins were resuspended in 1X SDS-PAGE solubilization 
buffer according to the final OD620 of the culture, and analyzed by SDS-PAGE and 
immunoblotting with antisera specific for YopM and LcrG.  LcrG C34S, LcrG C34A, and 
several mutants of the LcrG 52-73 region (deletion mutants Δ52-57, Δ58-62, Δ63-67, Δ68-73, 
Δ52-73; and point mutants I56N, K57E, K57L, R61E, R61L, I67N, K68E, K68L and L63N) 
were tested by the Yop secretion assay.   
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2.5 LcrV crystallization 
2.5.1 Crystallization and Data Collection  
LcrV was purified and concentrated to 22 mg/ml in 50 mM NaCl, 20 mM Tris-HCl, pH 8.0.  
Crystallization screenings were conducted at 20 °C in Compact Clover (Emerald Biosystems) 
sitting drop vapor diffusion plates using 0.5 µL of protein and 0.5 µL of crystallization solution 
equilibrated against 75 µL of the crystallization solution. LcrV yielded initial crystals, which 
formed plate clusters (Figure 3-3A, B), in approximately 24 hours from the IndexHT screen 
(Hampton 5 Research) conditions D8 (25% PEG 3350, 100 mM Hepes pH 7.5) and D9 (25% 
PEG 3350, 100 mM Tris pH 8.5).  The crystallization conditions were refined using the pHat 
buffer screen (Emerald Biosystems), and 25% PEG 3350, 100 mM Bicine pH 7.0 condition 
yielded prismatic crystals which were used for data collection (Figure 3-3C).  Single crystals 
were transferred to a fresh drop of a cryoprotectant solution containing 80% crystallization 
solution and 20% PEG 400.   
A peptide construct of LcrV’s binding partner, LcrG, spanning residues Ser 52 to Arg 73 was 
also used for crystallization screening of the complex.  A 50 mM stock solution of the LcrG 
peptide was prepared by dissolving 3.3 mg in 24.5 uL of 50 mM NaCl, 20 mM Tris-HCl pH 8.0.  
5 uL of the 50 mM LcrG peptide was mixed with 345 uL of the concentrated LcrV to give final 
concentrations of 0.59 mM and 0.71 mM respectively.  In addition, purified LcrV, LcrG7-73 C34S 
and also a size exclusion chromatography (SEC) isolated complex were sent for crystallization.  
However, the efforts to co-crystallize LcrG and LcrV in complex were not successful. 
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2.5.2 Structure Solution and Refinement  
X-ray diffraction data was collected by Kevin Battaile (Argonne National Laboratory) and the 
crystal structure was solved by Scott Lovell (Director, Protein structure Laboratory at the 
University of Kansas).  Diffraction data were collected at the Advanced Photon Source beamline 
17ID (IMCA-CAT) using a Dectris Pilatus 6M pixel array detector.  Diffraction data were 
integrated and scaled with XDS (17) and Scala (18) respectively.  The Laue class was checked 
with Pointless (18) which indicated that 2/m was correct and the likely space group was P21.  
Structure solution was conducted with Phaser (19) via the Phenix (20) interface using a 
previously determined structure of LcrV (PDB: 1R6F) (5) as the search model.  Following 
manual model building with Coot (21), the structure was improved by automated model building 
with Arp/warp (22).  Structure refinement and additional model building were performed with 
Phenix and Coot respectively.  Disordered side chain residues were truncated to the point to 
which electron density could be observed.  Structure validation was conducted with Molprobity 
(23).  Crystallographic data are provided in Table 1. 
2.6 Size Exclusion Chromatography (SEC) of LcrV, LcrG7-73 C34S and the complex 
After purification, LcrV and LcrG7-73 C34S were concentrated to 0.39 mM and 0.851 mM 
respectively using Amnicon Ultra 3K (Milipore).  The proteins were dialyzed overnight in SEC 
buffer (300 mM NaCl, 20 mM Tris-HCl, pH 8.0), filter sterilized, and applied to a Superdex 75 
(column height 51 cm, bed volume ~ 300 ml) analytical size exclusion column (GE Healthcare) 
equilibrated with 1 CV (column volume) of 300 mM NaCl, 20 mM Tris-HCl, pH 8.0.  The buffer 
was degassed and filtered prior to use.  2 ml volume of 0.3 mM LcrG7-73 C34S, 0.1 mM of LcrV 
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and LcrG7-73 C34S-LcrV complex (0.184 mM of LcrG7-73 C34S and 0.23 mM LcrV) in a 1:1.2 
ratio were loaded separately to the column and three individual runs were carried out.  The 
typical parameters used for the run were: flow rate - 1 ml/min, pressure - 0.3 MPa, elution 
fraction size - 6 ml and length of elution (CV) - 1.5.  Protein standards such as Blue Dextran 
(200 kDa), Albumin (66 kDa), Carbonic anhydrase (29 kDa), Cytochrome C (12.4 kDa) and 
Aprotonin (6.5 kDa) were used to calibrate the column and generate a standard curve.  Using the 
equation 
                                                                        (2.1) 
where Ve = elution volume, V0 = void volume and Vc = geometric column volume, Kav was 
calculated.  By substituting the Kav in the equation of the standard curve (y = - 0.4207x + 2.1177, 
where y = Kav and x = molecular weight in dalton) the molecular weights were determined. 
2.7 Surface Plasmon Resonance (SPR)  
Surface Plasmon Resonance (SPR) was used to measure the binding affinity between LcrG and 
LcrV using a Biacore 3000 instrument (Biacore, Uppsala, Sweden).  The assays were performed 
at 25° C using freshly prepared and degassed running buffer (10 mM HEPES-NaOH, 150 mM 
NaCl, 0. 005% (v/v) Surfactant P-20, pH 7. 4).  Unlabeled LcrG7-73 C34S and LcrG7-73 were 
dialyzed overnight.  The experiments were carried out using a CM5 chip and a 1:1 (v/v) mixture 
of 400 mM 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide (EDC) (Sigma), and 100 mM N-
hydroxysuccinimide (NHS) (Sigma) was used to activate the carboxymethylated dextran surface 
of the chip.  LcrG7-73 C34S (ligand) was diluted to 15 µg/ml in immobilization buffer (10 mM 
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sodium acetate, ph 4.5) and injected into the flow cell (flow cell 2/test cell) for direct amine 
coupling.  After ligand injection, blocking buffer (1 M ethanolamine, pH 8.5) (Sigma) was 
passed over the surface to deactivate the remaining uncoupled surfaces on the CM5 chip.  A 
control flow cell (flow cell 1) was prepared by injecting the EDC/NHS solution, followed by the 
blocking buffer.  These three steps of were performed for 7 mins at a flow rate of 10 µl/min and 
resulted in the direct coupling of LcrG7-73 C34S to the test cell of the CM5 chip.  Varying 
concentrations (12.5 µM, 25 µM, 50 µM and 100 µM) of the analyte, LcrV (dialyzed overnight 
in running buffer) were then injected into both the flow cells at 40 µl/min.  This was followed by 
surface regeneration using 20 µl pulses of regeneration buffer (10 mM glycine, pH 1.7).  Non-
specific binding of the analyte to the surface of the chip was determined from flow cell 1, and 
was substracted from the raw data.  The experiment was repeated with LcrG7-73 using 50 µM of 
the analyte concentration.   
Apparent dissociation constants (Kd) between PcrGFL or PcrG9-76 and PcrV were measured by 
surface plasmon resonance (SPR) using a Biacore 3000 instrument (Biacore, Uppsala, Sweden).  
Biacore assays for PcrG were performed by Bryce Nordhues (7).  A 1:1 (v/v) mixture of 400 mM 
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide (EDC) (Sigma) and 100 mM N-
hydroxysuccinimide (NHS) (Sigma) was prepared and immediately injected into two flow cells 
of a CM5 chip to activate the carboxymethylated dextran surface.  Lyophilized anti-polyhistidine 
antibodies (R&D Systems, Inc.) were resuspended to 25 µg/mL in immobilization buffer (10 
mM sodium acetate, pH 5.0) and injected into the 2 activated flow cells for amine coupling.  The 
anti-polyhistidine antibodies recognize the C-terminal His6 tag at the end of the PcrG constructs.  
The identification of the complex is described in the following paragraph.  Remaining uncoupled 
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surfaces were inactivated by injection of blocking buffer (1 M ethanolamine, pH 8.5) (Sigma).  
Activation, coupling, and blocking steps were performed for 7 min at a flow rate of 10 µL/min 
resulting in anti-polyhistidine direct coupling of ~14,000 response units (RUs) in both flow cells.  
The assays were carried out at 25° C using freshly prepared and degassed running buffer (10 mM 
HEPES-NaOH, 150 mM NaCl, 0.005% (v/v) Surfactant P-20, pH 7. 4).  Unlabeled PcrGFL or 
PcrG9-76 (fused to C-terminal GB1-His6 tag) was dialyzed overnight in running buffer and 
immobilized to the anti-polyhistidine coated surface of flow cell 2 by injection of 6-9 µL of 1 
µg/mL protein at 10 µL/min.  Varying concentrations (2-32 nM) of the PcrV analyte (TEV 
cleaved and dialyzed overnight in running buffer) were then injected in both flow cells at 40 
µL/min for 3 mins over immobilized PcrGFL-GB1-His6 (200 RU) and PcrG9-76-GB1-His6 (104 
RU).  Immobilization of the ligand and binding of analyte was repeated for each PcrV 
concentration followed by surface regeneration using 20 µL pulses of regeneration buffer (10 
mM glycine, pH 2.0).  Non-specific binding of the analyte to the anti-His6 antibody coated 
surface and the bulk effect from the buffer were determined from flow cell 1 and subtracted from 
the raw data.  The Kd values were calculated using BIAevaluation 4.1 software.  As an additional 
control, the above steps were repeated using only the TEV cleaved GB1-His6 tag as the ligand 
immobilized (108 RU) to the anti-polyhistidine coated surface to verify that the fusion tag did 
not contribute to binding.  Since we only tested the effect of GB1-His6 tag, and no other 
molecule was present, no binding effect was seen. 
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2.8 Fluorescense polarization (FP)  
Fluorescense polarization (FP) was also used to measure the binding affinity between LcrG and 
LcrV.  Purified LcrV and LcrG7-73 C34S were dialyzed overnight at room temperature in 1× PBS 
at pH 7.4.  The fluorescent dye fluorescein-5-maleimide (F5M) (4 mgs) was dissolved in 1 ml of 
DMSO and the microcentrifuge tube was immediately wrapped in aluminium foil.  A 10 ml 
labeling reaction was used for both LcrG7-73 and LcrGFL by combining 0.467 µmoles of protein, 
4.67 µmoles of TCEP (10 fold excess) and 9.35 µmoles of the dye (20 fold excess), and the rest 
of the volume was made up with 1× PBS pH 7.4.  The protein and TCEP mixture was stirred at 
room temperature for 20 minutes, after which the dye was slowly added dropwise to the protein 
while mixing.  The labeling reaction was continued for 3 hrs in the dark at room temperature.  
Excess dye was removed from the reaction mixture by extensive dialysis in buffer (1× PBS pH 
7.4).  Finally, the F5M-labeled protein was passed several times through an Amnicon Ultra 
Centrifugation filter until the flow through was colorless.  UV-vis spectroscopy was used to 
determine the extent of labeling in the protein.  The FP datasets were then acquired using a 
Varian Cary Eclipse Fluorescence Spectrophotometer.  This method yielded a poor labeling 
efficiency of the LcrG constructs.  A different labeling strategy was tried with GB1-LcrG7-73 
using 10 µM protein, 10 µM TCEP (allowed to react for 20 mins) and 40 µM dye (allowed to 
react for 3 hrs).  The reaction was then quenched with 1 mM DTT, concentrated to 1 ml using an 
Amnicon Ultra filter (3K) and desalted twice using Sephadex G50 (Sigma) columns.  The data 
for the FP experiment is not shown in this dissertation, as the LcrG constructs could not be 
labeled properly.  The poor labeling of LcrG, resulted in a linear curve that did not reach 
saturation. 
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CHAPTER 3: Crystal structure of the Yersinia pestis type III secretion system tip protein 
LcrV refined to 1.65 Å 
3.1 Introduction 
The pathogenesis of Yersinia pestis, is strongly dependent on the plasmid encoded type III 
secretion system (T3SS), which functions by injecting effector Yops (Yersinia outer proteins) 
into the host cell cytosol (1, 2).  Broadly, the T3SS or injectisome is composed of structural 
proteins, effector proteins, and chaperones (3, 4).  The structural component of the Y. pestis 
T3SS (also known as the Ysc-Yop system) is a needle apparatus that comprises a membrane 
embedded basal complex, an external needle, a tip complex, and a translocon (Figure 1-1).  Y. 
pestis responds to host cell contact by assembling the translocon that subsequently creates a pore 
in the host cell membrane and allows the delivery of effector Yops into the cytosol of targeted 
host cells.  These effector Yops then collectively function by disturbing cytoskeletal dynamics, 
preventing phagocytosis, and blocking the production of pro-inflammatory cytokines, thereby 
favoring the survival of Y. pestis inside the host (1, 2). 
In the Y. pestis T3SS, the tip complex is formed by several copies of a hydrophilic protein, LcrV 
(326 residues), that forms a distinct structure at the tip of the needle (5). LcrV is a 
multifunctional protein that plays an essential role in the pathogenicity of Y. pestis (6-10).  
Firstly, LcrV functions as host cell sensor because of its extracellular localization (11, 12).  
Secondly, LcrV, along with two other hydrophobic proteins (YopB and YopD), is indispensable 
for the delivery of effector proteins into the host cytosol (2, 3, 9, 11, 13, 14).  Thirdly, LcrV 
serves as a platform for the assembly of the translocation pore complex (10, 13).  Finally, LcrV 
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forms a complex with its cognate chaperone, LcrG while inside the cytoplasm to regulate the 
secretion of effectors (15, 16). 
The closest homolog of LcrV is PcrV, the tip protein of the Pseudomonas aeruginosa T3SS.  
LcrV shares 37% sequence identity and 65% sequence similarity (17) with PcrV. LcrV and PcrV 
can be grouped together in the Ysc family as the V-tip proteins (3, 17).  The crystal structure of 
LcrV (residues L24-K326) was determined in 2004 at a resolution of 2.2 Å using a construct 
containing triple mutations (K40A/D41A/K42A) in a C273S background (PDB # 1R6F) (18).  
The C273S point mutation facilitated protein purification.  Since then, crystal structures of other 
T3SS tip proteins like the Shigella IpaD (19), the Salmonella SipD (20, 21), and the 
Burkholderia BipD tip proteins (19, 22) have been determined.  These crystal structures have 
revealed structural similarities as well as differences in the T3SS tip proteins.  Here, the refined 
crystal structure of LcrV without the triple mutations but in a C273S background is reported at a 
resolution of 1.65 Å.  The refined structure contains prominent differences in the N-terminal 
domain of LcrV when compared to the previous crystal structure (1R6F).  Notably, the N-
terminal domain of LcrV forms the base of the tip complex, playing an important role in the 
proper assembly of the translocon by allowing for the correct insertion of the translocon protein 
YopB into the host membrane (13).  The most notable differences between the refined structure 
of LcrV and 1R6F are near the site of the triple mutations (K40A/D41A/K42A) in 1R6F.  Thus, 
this refined crystal structure of LcrV represents a more native form of the tip protein and is 
expected to be functionally more relevant.  
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3.2 Results 
3.2.1 Expression and purification of LcrV 
As described in section 2.1.2 the design of LcrV construct was based on the original crystal 
structure of LcrV (18) by truncating the disordered ends with a C273S background mutation.  
LcrV (residues G28-D322) was expressed in E. coli BL21 (DE3) DNAY cells as an N-terminal 
His6-GB1 fusion protein.  The GB1 tag contained a hexahistidine tag to aid in nickel affinity 
purification and a TEV protease cleavage site to allow the recovery of purified LcrV after 
removal of the His6-GB1 tag.  The fusion protein was over-expressed in soluble form in E. coli, 
purified under native conditions, and digested with TEV protease to obtain purified LcrV 
(Figure 3-1).  The purified LcrV yielded millimolar amounts of protein for crystallization 
studies. 
3.2.2 Circular Dichroism and Thermal Denaturation studies of LcrV 
Circular Dichroism (CD) spectra of LcrV displayed two characteristic minima at 222 nm and 208 
nm, suggesting LcrV has a significant amount of helical structure (Figure 3-2).  The thermal 
denaturation curve of LcrV displayed a single transition at around 80 °C (Figure 3-2).  This 
showed high thermal stability of LcrV, which is in good agreement with the studies of Espina et 
al. (23). 
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Figure 3-1.  SDS-PAGE showing the purification of LcrV by Ni+2 affinity chromatography.  (A) 
Results of first Ni+2 column purification showing flow-through (FT), wash, and fractions eluted 
from the column.  Fractions eluted from the column represent the purified LcrV fused to His6-
GB1 tag.  (B) Results of TEV digestion of LcrV where “U” (uncut) is the purified LcrV fused to 
His6-GB1 tag and “C” (cut) is the TEV protease digested mixture showing both LcrV (red arrow) 
and the His6-GB1 tag (blue arrow).  FT and wash fractions show the purified LcrV after TEV 
digestion.  “ST” represents the strip fraction, which shows the His6-GB1 tag after stripping the 
column with 35 ml of 0.5 M EDTA.
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Figure 3-2.  CD and thermal denaturation spectra of LcrV.  (A) CD spectra acquired at 25 °C.  
(B) Thermal denaturation plot of LcrV.  (Molar ellipticity θ (deg·cm2·dmol-1) ×  10-6). 
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3.2.3 Crystal structure of LcrV 
LcrV yielded initial crystals in approximately 24 hours from the IndexHT screen conditions D8 
(25% PEG 3350, 100 mM Hepes pH 7.5) and D9 (25% PEG 3350, 100 mM Tris-HCl pH 8.5) 
(Figure 3-3A, B).  Following refinement with the pHat buffer screen, LcrV yielded prismatic 
crystals, which were used for data collection (Figure 3-3C).  Crystallographic data are provided 
in Table 1.  The final model contained residues G28 to L319, a PEG 400 molecule and 149 
water molecules (Figure 3-4).  Overall, the refined structure of LcrV was similar to that reported 
previously (PDB: 1R6F) (18) with an RMSD between Cα atoms (244 residues) of 1.62 Å 
(Figure 3-5A) as determined using the secondary structure matching (24) routine in Coot (25).  
Residues from K261 to P279 could not be resolved owing to poor electron density due to 
disorder.  The overall shape of the protein structure can be described as a “dumbbell-shaped” 
made up of a central coiled coil region connecting two domains (18).  Like 1R6F (18), the 
present three-dimensional structure of LcrV also showed that it is highly α-helical with 55% of 
residues present in twelve α-helices (α1- α12) while, 7% of the residues form six β-strands (β1- 
β6) and the remaining 32% of the residues are in random coils.  The N-terminal globular domain 
is formed by six helices (α1-α6) that packs on one end of a long central coiled coil formed by 
helix α7 and helix α12, and two anti-parallel beta strands (β1 and β2).  The central coiled coil 
connects to the C-terminal globular domain formed by a mix of alpha helices and beta strands.  
The bulk of this mixed α/β domain is unstructured, as compared to the N-terminal globular 
domain, and is composed of coils and turns connecting short helices and beta strands.  It contains 
four short helices (α8-α11) and four anti-parallel beta strands (β3- β6).  
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Figure 3-3.  Crystals of LcrV obtained from (A) Hampton Index D8 (B) Hampton Index D9 and 
(C) following refinement with the pHat buffer screen. 
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Table 1.  Crystallographic data for LcrV (G28-D322, C273S) refined to 1.65 Å resolution. 
 LcrV (G28-D322, C273S) 
Data Collection  
Unit-cell parameters (Å, o) a=39.51, b=51.44, c=65.18,  
β=92.00 
Space group P21 
Resolution (Å)1 51.44-1.65 (1.74-1.65) 
Wavelength (Å) 1.0000 
Temperature (K) 100 
Observed reflections 103,407 
Unique reflections 31,392 
Mean <I/σ(I)>1 18.0 (2.2) 
Completeness (%)1 99.3 (99.8) 
Multiplicity1 3.3 (3.3) 
Rmerge (%)1, 2 3.4 (50.5) 
Rmeas4 4.0 (60.3) 
Rpim4 2.2 (32.6) 
Refinement  
Resolution (Å) 34.33-1.65 
Reflections (working/test) 29,790 / 1582 
Rfactor / Rfree (%)3 18.0 / 22.3 
No. of atoms (protein / PEG 400 / water) 2,219 / 10 / 153 
Model Quality  
R.m.s deviations   
Bond lengths (Å) 0.015 
Bond angles (o) 1.436 
Average B factor (Å2)  
All Atoms 28.8 
Protein  28.3 
PEG 400 43.8 
Water 35.6 
Coordinate error based on maximum 
likelihood (Å) 
0.46 
Ramachandran Plot   
Most favored (%) 98.9 
Additionally allowed (%) 1.1 
 
1) Values in parenthesis are for the highest resolution shell. 
2) Rmerge = ΣhklΣi |Ii(hkl) - <I(hkl)>| / ΣhklΣi Ii(hkl), where Ii(hkl) is the intensity measured for the ith reflection 
and <I(hkl)> is the average intensity of all reflections with indices hkl.  
3) Rfactor = Σhkl ||Fobs (hkl) | - |Fcalc (hkl) || / Σhkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 5% 
of randomly selected reflections that were not included in the refinement. 
4) Rmeas = redundancy-independent (multiplicity-weighted) R (26).  Rpim = precision-indicating (multiplicity-
weighted) R (27, 28). 
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There are significant differences between the earlier structure of LcrV (1R6F) and the refined 
structure presented herein.  At the N-terminal domain, there are differences in residues G28-N43, 
I46-V63 and Y77-Q95 (Figure 3-5B).  In 1R6F, helix α1 starts at G28 (residues G23-H27 could 
not be modeled in 1R6F).   However in the current structure, residues G28-S30 formed a random 
coil with helix α1 starting only at residue V31.  Further, the relative orientation of helix α1 is 
shifted as compared to the helix α1 of 1R6F.  In the current structure, residues I46-V63 formed 
an ordered loop that packs at the C-terminal end of one of the helices (helix α12) of the central 
coiled coil.  In 1R6F, residues K49-V63 lacked electron density and were not visible.  Most of 
the notable differences between the structures of 1R6F and the refined structure are close to the 
site of the triple mutations present in 1R6F.  Another difference is that while the residue Y90 is 
not visible in 1R6F, it could be resolved in the current refined structure.  Additionally, the helical 
turn spanning residues Y77-Q95 are oriented differently in the two structures.  In 1R6F the 
residues N260-D275 could not be modeled.  Similarly in our model the residues K261 to P279 
could not be modeled due to disorder. 
3.3 Discussion 
3.3.1 Comparison of the type III secretion system tip protein structures 
The T3SSs of Yersinia pestis, Pseudomonas aeruginosa, and Aeromonas salmonicida belong to 
the Ysc family of injectisome, while the T3SSs of Salmonella typhimurium, and Shigella flexneri 
belong to the Inv-Mxi-Spa family of injectisomes (3, 11, 17).  Though there is a low level of 
sequence identity (< 20 %) among the different families of tip proteins, the sequence 
conservation is high (~ 30-50 % sequence identity) within the tip proteins of the same family.   
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Figure 3-4.  Crystal structure of LcrV refined to 1.65 Å resolution.  The LcrV structure can be 
divided into three domains: N-terminal domain (red), the less structured domain of mixed α-
helices and β-strands (green) and the coiled coil domain (blue). 
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The tip protein LcrV is more closely related to PcrV from Pseudomonas as compared to SipD, 
IpaD and BipD.  Despite the low level of sequence conservation among the different families of 
tip proteins, they share a common topology consisting of the central coiled coil connected by two 
domains (Figure 3-6).  The central coiled coil is highly conserved among the T3SS tip proteins 
(12), suggesting it plays an important role in type III secretion (12, 29).  Recently, others have 
shown that the central coiled coil of SipD is the site of protein-protein interactions with the PrgI 
needle protein and the SipD-PrgI interaction plays a critical role in the assembly of the needle 
apparatus (21, 30).   
There are however significant differences between LcrV and the tip proteins IpaD, BipD and 
SipD with respect to the N-terminal domain (12, 20).  In IpaD, BipD, and SipD the N-terminal 
region (pink in Figure 3-6) forms an α-helical hairpin, which functions as a self-chaperone for 
these tip proteins (12, 19, 22).  Howevre, this α-helical hairpin domain is absent in LcrV.  
Another T3SS protein, LcrG, acts as a chaperone for LcrV by forming an LcrG-LcrV complex 
(12, 15, 16, 31, 32).  Another difference between LcrV and the self-chaperoned tip proteins 
(IpaD, BipD, and SipD), is that the C-terminal helix of LcrV is bent and has a kink, whereas in 
the other tip proteins the equivalent helix is straight (12) (Figure 3-6).  These structural 
differences suggest that the needle tip assembly process may vary between different T3SS 
families. 
3.3.2 Significance of the N-terminal globular domain in LcrV 
Results from scanning transmission electron microscopy (STEM) revealed that LcrV formed the 
tip complex on the Yersinia enterocolitica needle and consists of three distinct parts with a head,  
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Figure 3-5.  Comparison of the refined crystal structure of LcrV with 1R6F.  (A) Alignment of 
the refined crystal structure of LcrV and 1R6F.  The boxed area shows the N-terminal globular 
domain of LcrV.  (B) Comparison of the differences in the N-terminal globular domain of the 
refined structure of LcrV with that of 1R6F.   
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Figure 3-6.  Comparison of the tip proteins from different bacterial species:  (A) LcrV from 
Yersinia pestis, (B) BipD from Burkholderia pseudomallei, (C) IpaD from Shigella flexneri, and 
(D) SipD from Salmonella typhimurium.  The central coiled coil is colored blue and the mixed 
α/β domain is colored green.  The N-terminal domain of BipD, IpaD and SipD adopt an α-helical 
hairpin (pink), followed by short α-helices (red).  The N-terminal α-helical hairpin domain is 
absent in LcrV.  Instead, the LcrV N-terminal region forms a globular domain (red).  The kinked 
helix in LcrV and the straight helices in BipD, IpaD, and SipD are labeled. 
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a neck and a base (5).  The importance of the N-terminal globular domain of LcrV was 
demonstrated by Broz et al. (13) by forming hybrid proteins.  Taking advantage of the fact that 
Aeromonas AcrV and Pseudomonas PcrV can form tip complexes on Y. enteroclolitica needle 
(5), Broz et al. (13) constructed chimeric hybrid proteins with the N-terminal domain from one 
protein while the coiled coil and the C-terminal globular domain from another protein.  All these 
hybrid proteins could complement an lcrV deletion strain.  The AcrV hybrids (LcrV-AcrV and 
AcrV-LcrV) were capable of forming functional tip complexes, which was assessed based on as 
the ability of these proteins to form functional pores in red blood cells (RBC).  However, PcrV 
and PcrV-LcrV hybrid could not form functional pores and was unable to insert the YopB 
translocon protein efficiently into the RBC membranes.  Interestingly enough, the PcrV hybrid 
consisting of the LcrV N-terminal domain (LcrV-PcrV) could successfully form functional 
pores.  This highlighted the importance of the N-terminal domain of LcrV as a platform for the 
assembly of the translocation pore complex by allowing the efficient insertion of YopB into the 
host cell membrane (13).  
STEM results on the hybrid tip complexes performed by Broz et al. (5, 13) showed that the size 
of the head and base domains differs among the chimeric hybrid proteins due to the different 
sizes of the globular domains in AcrV, PcrV, and LcrV.  These differences suggested that the N-
terminal domain of LcrV forms the base of the tip complex.   
The refined structure of LcrV reported herein using wild type residues in the N-terminal domain 
would thus be important in studies of LcrV-translocon interactions.  
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CHAPTER 4: Structural characterization of the Yersinia pestis tip protein chaperone LcrG 
4.1 Introduction 
An important determinant of pathogenicity of Yersinia pestis is its ability to assemble a protein 
export machinery, the type III secretion system (T3SS) (1, 2).  The needle apparatus of the T3SS 
is assembled from structural proteins that form the base, an external needle, a tip complex, and a 
translocon (3).  In addition to structural proteins, effectors and chaperones are also required for 
the proper function of the T3SS (3).  In Yersinia, the tip complex is formed by several copies of 
LcrV (326 residues) (4) and while inside the bacterial cytosol, LcrV is chaperoned by a smaller 
protein, LcrG (95 residues) (5, 6).  LcrG functions as a chaperone of the LcrV tip protein by 
facilitating its secretion (6, 7).  
The secretion of Yops by the Y. pestis T3SS is a highly regulated process, and Yops are secreted 
only upon contact with the host cells (8).  In vitro, the concentration of Ca+2 plays an important 
role in regulation of Yop secretion.  The presence of millimolar amounts of Ca+2 prevents Yop 
secretion, while removal of Ca+2 from the growth medium results in Yop secretion (9, 10).  
Several proteins are involved in regulating Yop secretion, among which, LcrG and LcrV play 
important roles in this regulation process.  LcrG acts as a negative regulator of Yop secretion, i.e. 
increased levels of LcrG result in blockage of Yop secretion (10, 11).  Deletion of the gene 
encoding LcrG results in the loss of regulation of Yop secretion leading to constitutive 
expression and secretion of Yops regardless of Ca+2 concentration (6, 11-13).   
LcrG is functionally versatile and has multiple roles in type III secretion.  It is involved in 
regulating the secretion of Yops, and it facilitates the targeting of Yop effectors into the host 
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cells (7, 10, 11).  Additionally, it serves as a chaperone to the tip protein, LcrV (6, 7).  Unlike 
chaperones of effectors, translocators and needle proteins (14-16), much less is known about the 
atomic structures of the chaperones of tip proteins.  The tip proteins from Salmonella 
typhimurium (SipD), Shigella flexneri (IpaD) and Burkholderia pseudomallei (BipD) have an N-
terminal α-helical hairpin domain that acts as a self-chaperone for these proteins (17-20).  
However, the tip protein of Yersinia pestis (LcrV) lacks this self-chaperoning domain.  Hence, it 
has been suggested by others that LcrG, which serves as a chaperone for LcrV adopts a similar 
coiled coil structure analogous to the self-chaperoning domains of the other tip proteins (17, 18, 
20) (Figure 4-1).  However, the atomic structures of the LcrG family of chaperone proteins 
remain unknown.  
A goal of this research was to determine the structure of LcrG by using NMR spectroscopy and 
other biophysical methods.  In contrast to the hypothesis that LcrG forms a coiled coil structure, 
data from NMR and CD spectroscopy show that LcrG is a flexible protein with an α-helical 
secondary structure, and the protein lacks a tertiary fold.  This knowledge about the structure of 
LcrG is important in elucidating the mechanism by which it achieves its functional versatility. 
4.2 Results 
4.2.1 Expression and purification of LcrG 
The LcrG constructs were expressed in E. coli as N-terminal His6-GB1 fusion proteins.  The His6 
tag aided in the nickel affinity purification.  The TEV protease cleavage site was used to obtain 
the purified proteins after digestion by TEV protease to remove the His6-GB1 tag.  
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Figure 4-1.  Comparison of crystal structures of T3SS tip proteins:  (A) LcrV from Yersinia 
pestis, (B) BipD from Burkholderia pseudomallei, (C) IpaD from Shigella flexneri, and (D) SipD 
from Salmonella typhimurium.  The central coiled coil is colored blue and the mixed α/β domain 
is colored green.  The N-terminal domain of BipD, IpaD and SipD adopt an α-helical hairpin 
(pink), which are proposed to function as self-chaperones for the respective tip proteins.  Instead, 
the LcrV N-terminal region forms a globular domain (red).  Since the N-terminal α-helical 
hairpin is absent in LcrV, the chaperone LcrG has been modeled based on the N-terminal domain 
of IpaD (20). 
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The fusion proteins were expressed in soluble forms in E. coli and purified under native 
conditions followed by TEV protease digestion.  All the constructs described in this chapter 
produced high yields of protein that facilitated NMR studies. 
4.2.2 Designing an ideal LcrG construct for NMR studies 
Multiple sequence alignment of LcrG (95 amino acids) showed conservation with other members 
of the LcrG family of chaperone proteins (Figure 4-2).  Full-length LcrG (LcrGFL) showed a 
poor quality two-dimensional (2D) 1H-15N HSQC NMR spectrum where the amide peaks were 
barely resolved and the numbers of peaks were much less than expected from a 95-residue 
protein (Figure 4-3A).  Based on the secondary structure prediction by PSIPRED (21) (Figure 
4-2B), the disordered tails of LcrG were truncated, while maintaining the hydrophilic terminal 
residues to generate the truncated construct spanning residues Asp-7 to Arg-73 (LcrG7-73).  Using 
LcrG7-73 somewhat improved the 2D 1H-15N HSQC spectrum as compared to LcrGFL, but LcrG7-
73 did not yield an ideal NMR spectrum either.  Only 58% of the residues in the protein were 
represented in the 2D 1H-15N HSQC spectrum of LcrG7-73 and the peaks were broadened and 
poorly resolved (Figure 4-3B).  It was reasoned that this non-ideal NMR spectrum of LcrG7-73 
could be due to the presence of a native cysteine at position 34 (C34) (shown by an arrow in 
Figure 4-2A), and this C34 might be responsible for forming disulphide linkage and contribute 
to the aggregation of the protein.  Hence, the native cysteine (C34) was mutated into serine and 
alanine thereby creating the constructs LcrG7-73 C34S and LcrG7-73 C34A.  LcrG7-73 C34S 
yielded a better quality 1H-15N HSQC spectrum with sharp and well-resolved peaks (Figure 4-
3C) compared to LcrG7-73 C34A (Figure 4-4).  Since NMR is sensitive to the amount of DTT, it 
could not be used at the sufficient concentration.  
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Figure 4-2.  Multiple sequence alignment (MSA) of LcrG family of tip chaperones and 
secondary structure prediction for LcrG.  (A) MSA of LcrG family of proteins using 
CLUSTALW (22).  The homologous proteins were obtained from BLAST and denoted as 
follows: LcrG (from Yersinia pestis), LcrG (from Yersinia enterocolitica), PcrG 1 and 2 (from 
two different strains of Pseudomonas aeruginosa), LssG (from Photorhabdus asymbiotica) and 
AcrG (from Aeromonas hydrophila).  The green line denotes the region Asp-7 to Thr-40 in LcrG 
that is suggested to bind to LcrV using yeast two-hybrid assays (23).  The black arrow points to 
the cysteine at position 34.  (B) Result of secondary structure prediction for LcrG from PSIPRED 
(21).  Residues in random coil or helical regions are denoted by “C” or “H”, respectively.  A 
cartoon representation is also provided where the helices and random coils are represented as 
blue cylinders and black lines respectively. 
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To verify that the truncation of the flexible tails were essential to achieving the well-resolved 
NMR spectrum, LcrGFL C34S protein was expressed.  While the 2D 1H-15N HSQC spectrum of 
LcrGFL C34S was better than LcrGFL, it was poor compared to the 2D 1H-15N HSQC spectrum of 
LcrG7-73 C34S (Figure 4-4).  LcrGFL C34S showed a significant number of overlapping peaks 
and exhibited conformational heterogeneity (Figure 4-4), which possibly arose from the cis-trans 
isomerization of the prolines present at the flexible C-terminus of LcrG.  However, both LcrGFL 
C34S and LcrG7-73 C34S had similar biophysical characteristics as seen from the CD and thermal 
denaturation curves (Figure 4-6).  Additionally, both the LcrGFL C34S and LcrG7-73 C34S bind 
similarly to LcrV (Figure 5-10 in chapter 5).  The same set of LcrV residues were affected in the 
same manner when titrated with either LcrGFL C34S or LcrG7-73 C34S (Figure 5-10 in chapter 
5).  Therefore, I used LcrG7-73 C34S for NMR studies. 
4.2.3 Circular Dichroism and Thermal Denaturation 
Circular Dichroism (CD) spectra of LcrGFL, LcrG7-73, LcrG7-73 C34S, and LcrGFL C34S (Figure 
4-6) showed that the LcrG constructs are primarily α-helical in secondary structure as 
demonstrated by the characteristic minima at 222 and 208 nm.  The 222/208 nm ratios of LcrGFL 
, LcrG7-73 and LcrGFL C34S were ~0.8.  The 222/208 nm ratio of the LcrG7-73 C34S was ~0.7.  
The slight difference in the θ222 reading at 25 °C between the CD and thermal denaturation of the 
LcrGFL C34S, was due to the difference among the three thermal denaturation readings that was 
averaged.  Thermal denaturation curves of LcrGFL , LcrG7-73 , LcrGFL C34S and LcrG7-73 C34S 
showed that they unfolded in a non-cooperative manner without displaying a clear inflection 
point (Figure 4-6). 
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Figure 4-3.  2D 1H-15N HSQC spectra of (A) LcrGFL (B) LcrG7-73 and (C) LcrG7-73 C34S. 
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Figure 4-4.  CD (A), thermal denaturation (B), and 2D 1H-15N HSQC spectrum (C) of LcrG7-73 
C34A. 
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Figure 4-5.  2D 1H-15N HSQC spectrum of LcrGFL C34S shown with partial backbone 
assignments.  The residues in blue display conformational heterogeneity.  The intensity of the 
G92b peak is low, and hence not shown.  The position of G92b is indicated with black asterisk. 
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Figure 4-6.  CD and thermal denaturation spectra of the various LcrG constructs.  CD spectra 
were acquired at 25° C for (A) LcrGFL, (B) LcrG7-73, (C) LcrG7-73 C34S, and (D) LcrGFL C34S.  
Thermal denaturation plots of (E) LcrGFL, (F) LcrG7-73, (G) LcrG7-73 C34S and (H) LcrGFL 
C34S, (Molar ellipticity θ = (deg·cm2·dmol-1) × 10-5). 
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4.2.4 Functional characterization of LcrG C34S mutant in Yersinia pestis  
A Yop secretion assay was used to evaluate the functional significance of mutations on LcrG.  
The mutant protein (LcrG C34S) was expressed from a pBAD18 vector and tested with regards 
to Yop secretion in Y. pestis.  LcrG C34S mutant successfully complemented a ∆lcrG mutation, 
restoring Ca+2 regulated secretion of YopM proteins (Figure 4-7).  In other words, LcrG C34S 
secreted YopM only in the absence of Ca+2 and not in its presence, which is similar to behavior 
of wild type LcrG.  On the other hand, the null LcrG mutant constitutively secreted YopM both 
in the presence and absence of Ca+2.  The expression of YopM and LcrG proteins in whole cells 
was confirmed by immunoblotting with their respective antibodies.  Another construct, 
LcrGC34A was functional (Figure 4-7), and had similar secondary structure composition, 
compared to wild type LcrG (Figure 4-4).  However, further NMR studies were performed using 
the LcrGC34S construct because it gave better NMR data.   
4.2.5 LcrG backbone assignments   
The construct LcrG7-73 C34S was soluble at high concentrations and afforded millimolar amounts 
of purified protein.  Three-dimensional NMR datasets were acquired using 15N/13C LcrG7-73 
C34S for backbone resonance assignments.  Of the 67 backbone amides of LcrG7-73 C34S, 62 
were assigned (Figure 4-8).  However, the backbone amides of His-25, Arg-26, Glu-32, Lys-46 
and Met-45 were either in rapid exchange with the solvent or overlapped with other peaks, and 
hence could not be assigned.  The other overlapping peaks in the assigned LcrG7-73 C34S 
spectrum are indicated in Figure 4-8 with asterisks.  The backbone resonances of Ile-37, Ile-47 
and Phe-48 were assigned by 15N amino acid specific labeling of LcrG7-73 C34S as described in 
section 2.1.6 (Figure 4-8).   
77 
 
 
 
 
 
 
Figure 4-7.  Functional characterization of LcrG substitution mutants in Yersinia pestis.  Both 
mutants LcrG C34S and LcrG C34A are capable of complementing a ΔlcrG mutation, restoring 
Ca+2 regulated secretion of YopM proteins.  The ΔlcrG represents a non-functional deletion 
mutant of LcrG (Δ39-54), and hence the lower bands are seen in the whole cell blot of ΔlcrG. 
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Since there were two isoleucines (Ile-37 and Ile-47) that could not be assigned by the 3D 
datasets, a 2D 1H-15N HSQC of the point mutant I37A in addition to the 15N amino acid (Ile) 
specific labeling  (Figure 4-9) was used to confirm the assignment of the two isoleucines.  
Overlay of the two HSQC spectra, 15N LcrG7-73 C34S (black) and 15N Ile LcrG7-73 C34S (blue), 
showed the backbone amide peak positions of the five isoleucines (blue) (Figure 4-9A).  Of the 
five isoleucines, three (Ile-20, Ile-56 and Ile-67) were already assigned by using the 3D datasets.  
Figure 4-9B showed that upon superposition of the two HSQC spectra, 15N LcrG7-73 C34S 
(black) and 15N LcrG7-73 C34S I37A (red), there was absence of a red peak in one position for the 
backbone amide of I37A, thus identifying that peak as I37.  A similar 15N amino acid selective 
labeling approach was used to assign the backbone resonance of Phe-48 (Figure 4-9C).  Since 
there is only one Phe in LcrG, it could be assigned based simply on the selective labeling with 
15N-phenylalanine.  Examples of the carbon backbone connectivity of some of the representative 
LcrG residues are illustrated in Figure 4-10.   
Analysis of the secondary Cα and Cβ chemical shifts suggested the presence of three α-helices 
from residues Asp-7 to Gly-38, Glu-42 to Gly-50 and Ala-59 to Arg-73 (Figure 4-11).  If the Cα 
chemical shifts are consistently positive, it is denoted as a α-helix.  The random coil chemical 
shifts are determined as described in Chapter 2 (section 2.3.3).  However, the first α-helix (Asp-7 
to Gly-38) displayed low helicity compared to the other two helices.  These helices are separated 
by a very short three-residue linker between helix α1 and helix α2, and an eight-residue linker 
between helix α2 and helix α3.  
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Figure 4-8.  Assigned 2D 1H-15N HSQC spectrum of LcrG7-73 C34S.  Residue names are labeled 
next to their corresponding peaks.  Overlapped peaks are indicated with asterisk (A27* is 
overlapped with L18*; Y9*, I47* and L64* are all overlapped; E42* is overlapped with Q70*; 
M33* is overlapped with D36*.  Q15*, R61* and F48* were not resolved.  The intensity of the 
E54 peak is low and not shown.  The position of E54 is indicated with red asterisk.   
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Figure 4-9.  Overlay of 2D 1H-15N HSQC spectrum of LcrG7-73 C34S (black) with (A) 2D 1H-
15N Ile HSQC spectrum of LcrG7-73 C34S (blue).  The five isoleucines are marked next to their 
corresponding peak positions.  Arrows show the backbone resonances of Ile-37 and Ile-47, 
assigned by selective labeling and mutagenesis.  (B) 2D 1H-15N HSQC spectrum of LcrG7-73 
C34S I37A (red).  The arrow shows the assignment of the backbone resonance of Ile-37.  
Overlay of 2D 1H-15N HSQC spectrum of LcrG7-73 C34S (black) with (C) 2D 1H-15N Phe HSQC 
spectrum of LcrG7-73 C34S (magenta).  The arrow shows the assignment of the backbone 
resonance of Phe-48.   
81 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-10.  Representative strips of the 3D HNCACB spectrum of 15N/13C LcrG7-73 C34S 
spanning residues D7 to A16 (top) and E55 to D65 (bottom) to illustrate the backbone 
connectivity identified for LcrG7-73 C34S assignment. 
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Figure 4-11.  (A) Cα and (B) Cβ Secondary chemical shifts of LcrG7-73 C34S suggest the 
presence of three α-helical regions. If the Cα chemical shifts are consistently positive, it is 
denoted as an α-helix.  The positions of the helices are indicated.  The random coil chemical 
shifts are determined as described in Chapter 2 (section 2.3.3). 
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4.2.6 LcrG backbone dynamics 
The steady state heteronuclear {1H}-15N NOE and 15N backbone relaxation rates (R1 and R2) 
were acquired on LcrG7-73 C34S to assess the backbone dynamics of the protein.  The 
heteronuclear {1H}-15N NOEs provide a read out of fast protein backbone dynamics at the 
picosecond to nanosecond time scales.  Residues with {1H}-15N NOEs above 0.6 generally 
indicate that they form well-structured regions and can be qualitatively described as being rigid.  
Whereas residues with {1H}-15N NOEs between 0.4-0.6 suggest semi-rigid flexibility, and the 
residues with {1H}-15N NOEs below 0.2 indicate these residues are random coil.  The extreme 
terminal residues of LcrG7-73 C34S (Asp-7 and Arg-73) were in random coil flexibility as seen 
from their {1H}-15N NOE values of below 0.2 (Figure 4-12A).  Most of the residues in the α-
helices have semi-rigid flexibility as shown by their {1H}-15N NOEs that range between 0.4-0.6 
(Figure 4-12A).  There were a few residues in the beginning of α-helix 1 (Glu-8, Asp-10, Lys-
11, Lys-14, Ala-19) and one in the extreme end of α-helix 3 (Glu-72) that displayed higher 
flexibility, as indicated by their {1H}-15N NOE values of below 0.4 (Figure 4-12A).  
Interestingly, there were residues in all the three α-helices (Lys-28, Leu-29, Ala-43, Glu-66 and 
Arg-69) with {1H}-15N NOE values of above 0.6.  Additionally, residues outside the α-helices 
displayed {1H}-15N NOE values above 0.4, suggesting these regions have flexibility approaching 
that of a well-structured state.   
The 15N backbone relaxation rates (R1 and R2) indicated that the α-helices behaved with nearly 
similar backbone amide dynamics with respect to each other.  There is no appreciable difference 
in the relaxation rates from the beginning to the end of the protein (Figure 4-12B, C).  Residues 
(Arg-51 to Glu-55) in the linker region between α-helix 2 and α-helix 3 showed a uniform 
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decrease in R2 and increase in R1 (Figures 4-12B, C).  Interestingly, the penultimate residue of 
α-helix 1, Ile-37 and the linker residue Lys-57, showed increased R2 without a corresponding 
increase in R1.  This suggested chemical exchange on the µs-ms timescale for Ile-37 and Lys-57 
(Figure 4-12B, C).  Chemical exchange means that these residues can exist in multiple 
conformations.  Excluding these two residues, the relaxation rates remained almost uniform 
throughout the protein.  The gaps in all the datasets refer to the unassigned and overlapping 
peaks that have been omitted from the analyses. 
4.3 Discussion 
Despite the critical importance of the role of LcrG in the regulation of Yop secretion (7, 10, 11) 
no atomic structure is available for this small 95 amino acid protein.  It has been hypothesized, 
based on the structure of the self-chaperonin domain of tip proteins IpaD, BipD and SipD, that 
LcrG forms a coiled coil (17-20).  However, no experimental studies to validate this hypothesis 
were carried out.  Thus, NMR spectroscopy was used to obtain insight into the three-dimensional 
structure of LcrG. 
4.3.1 LcrG is a partially folded protein 
The initial attempt to use full-length LcrG for NMR characterization was not successful because 
of the non-ideal 2D 1H-15N HSQC spectrum of LcrGFL (Figure 4-3A). This was reasoned to be 
due to the disordered regions in LcrG.  By truncating the flexible tails of LcrG and mutating the 
single cysteine to serine, the construct LcrG7-73 C34S was generated that gave an ideal 2D 1H-15N 
HSQC spectrum for the NMR studies (Figure 4-3C).  This truncated LcrG from residues Asp-7  
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Figure 4-12.  (A) Heteronuclear {1H}-15N NOEs, (B) R1 and (C) R2 relaxation data for LcrG7-73 
C34.  The helical regions are shaded. 
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to Arg-73 included the minimum LcrG region (Asp-7 to Thr-40) required for interaction with 
LcrV (shown in Figure 4-2A with a green line) (23).  Along with CD spectroscopy and thermal 
denaturation, it was shown that all the four LcrG constructs (LcrGFL, LcrG7-73, LcrG7-73 C34S 
and LcrGFL C34S) have similar secondary structures and are primarily α-helical (Figure 4-6).   
NMR titrations using 13C ILE-LcrV showed that both LcrGFL C34S and LcrG7-73 C34S bind to 
the same surface of LcrV, as the same set of isoleucine residues in LcrV were perturbed on 
binding to either of the LcrG constructs (Chapter 5, Figure 5-10).  Thus the truncated LcrG 
behaved similarly to the full-length LcrG with respect to binding to LcrV.  Through a 
collaboration with Dr. Gregory V. Plano (University of Miami), the use of the C34S mutation 
was validated by showing that the C34S mutant can function as the wild type LcrG in Y.  pestis 
by restoring Ca+2 dependent regulation of effector Yop (YopM) (Figure 4-7).  Although this 
single cysteine (shown by an arrow in Figure 4-2A) is conserved in the Yersinia species, it is not 
conserved in homologous proteins from other bacterial species (Figure 4-2A).  Rather, it is 
replaced by a tryptophan in the other species (Figure 4-2A).  The cysteine is possibly not 
important in function and hence, mutating it to a similar amino acid like serine helped retain the 
function of LcrG while preventing the non-specific oligomerization mediated by disulfide bonds.  
Based on the observation that LcrG7-73 C34S retained wild type secondary structure and the fact 
that it produced an ideal 2D 1H-15N HSQC spectrum with sharp and well-resolved peaks, we 
used LcrG7-73 C34S for further NMR characterization.  The secondary chemical shift mapping 
(Cα and Cβ) derived from the backbone resonance assignments of LcrG7-73 C34S suggested that 
the secondary structure of LcrG is dominated by three α-helices (Figure 4-11).  Characterization 
of LcrG backbone dynamics by heteronuclear {1H}-15N NOE suggested that the α-helices  
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Figure 4-13.  A proposed model for the dynamic behavior of LcrG structure.  A protein can exist 
in any of the three states shown above.  State 1 is a representation of a random coil conformation, 
while state 3 represents a typical well-structured 3D conformation adapted by α-helical proteins.  
LcrG, however most likely is in state 2, i.e. it is a highly α-helical protein but it does not adapt a 
well-folded tertiary structure like state 3. 
88 
 
display semi-rigid flexibility and do not form well-structured regions.  However, there are 
residues in all the three α-helices with {1H}-15N NOE values of above 0.6 (Figure 4-12A), 
which implies that, although LcrG lacks a well-structured three-dimensional fold, it is not 
completely disordered and there are residues whose flexibility approach a more stable 
conformation.  The 15N backbone relaxation rates (R1 and R2) (Figure 4-12B, C) suggested that 
the α-helices behave with nearly similar backbone amide dynamics and LcrG tumbles as a single 
unit in solution.   
Surprisingly though and contrary to the earlier hypothesis of LcrG being a coiled coil, LcrG was 
shown to lack a compact tertiary structure.  A number of data were used to corroborate this 
conclusion.  First, the 2D 1H-15N HSQC spectra of the LcrG constructs (Figure 4-3A, B and C) 
displayed a narrow proton chemical shift range (<1 ppm), which suggests that the protein is 
either highly α-helical or unstructured.  Secondly, CD spectroscopy and thermal denaturation 
showed the absence of a distinct melting temperature, which indicates the lack of a closely 
packed tertiary fold (Figure 4-6).  Thirdly, data indicating a loosely packed helical protein can 
also be found from the molar ellipticity θ222/208 ratio of 0.7-0.8 (a θ222/208 ratio of 1.0 indicates a 
well folded helical protein) obtained from the CD spectra.  Finally as discussed above, the NMR 
backbone dynamics data suggested that the helices in LcrG lack a well-structured 3D state, and 
LcrG tumbles as a single unit in solution. 
Thus, our NMR and CD data point towards LcrG being a highly α-helical, yet intrinsically 
flexible protein lacking a compact tertiary fold (Figure 4-13).  
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4.3.2 Significance of LcrG as a partially folded protein 
The conformational dynamics of LcrG perhaps contribute to its functional versatility, which is a 
characteristic signature of many flexible proteins (24, 25).  The conformationally 
interchangeable nature of intrinsically flexible structures like LcrG ensures easier adaptation of 
distinct states required for carrying out multiple non-concurrent roles within the cellular 
environment.  Such intrinsically disordered proteins have also been observed among both 
effectors and structural proteins of the T3SS (16, 26). 
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CHAPTER 5:  Characterization of the interaction between Yersinia pestis tip protein LcrV 
and the chaperone LcrG 
5.1 Introduction 
The LcrV tip protein of the Yersinia pestis type III secretion system (T3SS) forms a stable 
complex with the chaperone LcrG (1-6).  This LcrG-LcrV complex plays an important role in the 
regulation of Yop secretion (1-3, 7).  The current model that explains the regulation of Yop 
secretion by LcrG and LcrV is the “Titration” model (Figure 1-3 in chapter 1) proposed by 
Nilles and coworkers (1-3).  According to this model, in the absence of host cell contact or in the 
presence of Ca+2, LcrG plugs the T3SS from the cytoplasmic face and prevents the secretion of 
Yops.  Upon host cell contact or in the absence of Ca+2, there is an upregulation of the expression 
of LcrV, which then titrates away LcrG by forming a stable LcrG-LcrV complex.  This relieves 
the negative block thereby allowing the secretion of Yops.  Thus, if LcrG-LcrV interaction is 
blocked, LcrG cannot be titrated away from the T3SS.  This would result in a constitutive 
blockage of secretion of Yops regardless of host cell contact or Ca+2 concentration. 
Direct binding between LcrG and LcrV has been demonstrated previously (1-6), and the results 
of yeast two-hybrid assays indicate that the N-terminus of LcrG is involved in the interaction 
with LcrV (3).  Lawton et al. (4) further demonstrated that LcrG and LcrV form a tight complex 
as indicated by their nanomolar binding affinity (Kd = 140 nM by SPR).  The coiled coil domain 
of LcrV has been shown to be the site of protein-protein interaction with LcrG (4, 5).  However, 
the atomic detail of this interaction is not well understood.  Since the LcrG-LcrV complex was 
not amenable to crystallization (Chapter 2), a primary objective of this research was to use NMR 
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spectroscopy to elucidate the details of the protein-protein interaction of the LcrG-LcrV 
complex.   
Here, the direct interaction between LcrG and LcrV was confirmed by size exclusion 
chromatography (SEC).  Further, the results of NMR experiments suggested that protein-protein 
interaction between LcrG and LcrV caused a global effect on the structure of LcrG and spans 
almost its entire length as opposed to local perturbations in the N-terminal region only.  The C-
terminus of LcrG (Ser-52 to Ile-67) was identified to be important in blocking the secretion of 
Yop effectors.  It has also been confirmed by NMR Spectroscopy that the coiled coil domain of 
LcrV is perturbed on binding to LcrG.   
5.2 Results 
5.2.1 Size exclusion chromatography of the LcrG7-73 C34S-LcrV complex 
Purified LcrV, LcrG7-73 C34S, and the LcrG7-73 C34S- LcrV complex (formed by mixing the two 
proteins in a 1:1.2 molar ratio) were separately loaded and run through a Superdex 75 size 
exclusion column (SEC) column (described in section 2.6).  Purified LcrV eluted from the SEC 
at 140 ml.  Purified LcrG7-73 C34S eluted at 164 ml.  The eluted LcrV corresponded to an 
approximate molecular weight of 43 kDa (the actual molecular weight of LcrV is 34kDa), based 
on the marker proteins used for calibration of the SEC column.  LcrG7-73 C34S corresponded to 
an approximate molecular weight of 22 kDa.  Notably, the molecular weight of LcrG7-73 C34S is 
8 kDa, which is consistent with its migration in SDS-PAGE (Figure 5-1B).  This is 
approximately one-third the molecular weight (22 kDa) at which it eluted from the SEC column.  
The LcrG7-73 C34S and LcrV complex co-eluted from the size exclusion column at 136 ml 
(Figure 5-1).  This corresponded to an approximate molecular weight of 47.8 kDa for the  
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Figure 5-1.  Size exclusion chromatography (SEC) showing (A) the elution profiles of LcrV in 
blue, LcrG7-73 C34S in red and the complex (LcrG7-73 C34S- LcrV mixed in a 1:1.2 molar ratio) 
in green.  The mAU readings for LcrV and LcrG7-73 C34S were multiplied five times to adjust 
the scale.  (B) The migration pattern of the peak fractions from SEC were analyzed by SDS-
PAGE.  Lane 1 corresponds to LcrG7-73 C34S (red arrow), lane 2 corresponds to LcrV (blue 
arrow), and lane 3 corresponds to the complex.  The trimeric nature of LcrG7-73 C34S seen in the 
SEC column (run at 4 °C) is not evident in the denaturing gel (SDS-PAGE), but a Native-PAGE 
would possibly have resolved this. 
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complex, which is roughly equal to the molecular weight of an LcrG-LcrV heterodimer (the 
predicted molecular weight of the heterodimer is 43 kDa).  Figure 5-1 shows the migration of 
peak fractions in SEC of LcrV, LcrG7-73 C34S, and the LcrG7-73 C34S- LcrV complex as well as 
the SDS-PAGE gel of the proteins. 
5.2.2 NMR titrations using 15N LcrG7-73 C34S 
NMR chemical shift mapping was used to characterize the interaction between LcrV and LcrG.  
15N LcrG7-73 C34S was titrated with unlabeled LcrV at molar ratios of 0.0, 0.5, 1.2, 2, 3, 4 and 
6.5.  Two-dimensional 1H-15N HSQC (8) spectra were acquired for each titration point and they 
were overlayed to monitor the changes in the HSQC spectra of 15N LcrG7-73 C34S upon binding 
to LcrV (Figure 5-2).  Majority of the residues of LcrG showed significant reduction in peak 
intensities with increasing molar ratios of LcrV (Figure 5-2).  The progressive reduction in peak 
intensities upon complex formation is the intermediate exchange time scale.  Additionally, some 
of the residues of LcrG appeared as new peaks (marked with asterisks in Figure 5-2) in the 2D 
1H-15N HSQC spectrum of 15N LcrG7-73 C34S upon complex formation.  The appearance of new 
peaks in the LcrG spectrum upon complex formation indicated that the interaction is in the slow 
exchange NMR time scale.  Slow exchange means tight binding and intermediate exchange 
means weaker binding.   
In order to identify the residues of LcrG that appeared as new peaks, three-dimensional NMR 
datasets were acquired on the 15N/13C LcrG7-73 C34S-LcrV complex in a 1:1.2 molar ratio.  
Residues Ser-52 to Arg-73 (except Arg-61) of LcrG appeared as new peaks upon complex 
formation and the rest of the protein (Asp-7 to Arg-51) showed significant reduction in peak  
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Figure 5-2.  Seven overlaid 2D 1H-15N HSQC spectra of LcrG7-73 C34S with increasing molar 
ratios of LcrV.  Backbone amide peaks that appeared in new positions on complex formation are 
marked with asterisks.  The rest of the backbone amide peaks showed significant reduction in 
peak intensities. 
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Figure 5-3.  Assigned 2D 1H-15N HSQC spectrum of the LcrG7-73 C34S- LcrV complex.  
Backbone amide peaks of residues Ser-52 to Arg-73 appeared in new positions upon complex 
formation.  The original peak positions of these residues are indicated.  Blue arrows point to the 
new peak positions (shown in red), whose names are also indicated.  The red asterisks indicate 
the new complex peaks (S52 and E54) whose intensities were low, and do not appear on the 
contour level of the spectrum shown. 
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intensities.  The assigned 2D 1H-15N HSQC spectrum of the complex (Figure 5-3) shows the 
assignments of the backbone resonances of the residues of LcrG that appeared in new positions. 
For R73 was the original position and R73 (colored red) was the new position of the residue Arg-
73.  A blue arrow is used to indicate the change in position of the peaks.  The residue Arg-69 
appeared in two new positions indicated in red as Arg-69.  The rest of the residues of LcrG are 
not marked in this figure as they remained in the same position as the free protein shown in 
Figure 4-7 (Chapter 4). 
To test if the flexible tails of LcrG would be important in binding to LcrV, 15N LcrGFL C34S was 
titrated with increasing amounts of unlabeled LcrV in molar ratios of 0.0, 0.25, 0.5, 1.0 and 2.  
Several peaks of LcrGFL C34S showed a significant reduction in peak intensities on complex 
formation with LcrV (indicated with arrows in Figure 5-4).  But this data was not consistent 
with the titration data using the truncated construct, 15N LcrG7-73 C34S.  The attempt to assign 
the backbone resonances of LcrGFL C34S was not successful as seen in Chapter 4 (Figure 4-5).  
This hindered any further work with the labeled LcrGFL C34S construct.  It was reasoned that 
owing to the flexibility of the tails and the conformational heterogeneity (Figure 4-5) arising 
from the cis-trans isomerization of the prolines present at the C-terminal end of LcrG, led to the 
inconsistent results.   
5.2.3 NMR titrations using 13C ILV-LcrG7-73 C34S 
In addition to the traditional 15N backbone labeling, 13C methyl labeling of the side chains of 
isoleucines, leucine, and valine (ILV) of LcrG7-73 C34S were also used.  The advantages of 13C 
methyl labeling of ILV are threefold.  Firstly, this reduces the complexity of the spectra making  
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Figure 5-4.  Five overlaid 2D 1H-15N HSQC spectra of LcrGFL C34S with increasing molar 
ratios of LcrV.  Backbone amide peaks that showed significant reduction in peak intensities are 
marked with arrows. 
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Figure 5-5.  (A) 2D 1H-13C HSQC spectrum of 13C ILV-LcrG7-73 C34S where the positions of 
the 13C methyl groups of Ile, Leu and Val are indicated.  (B) Amino acid sequence of LcrG7-73 
C34S showing the distribution of Ile (red), Leu (pink), and Val (blue).  
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analysis more amenable.  Secondly, the 13C methyl specific probes are more sensitive, as there 
are three protons in CH3 as opposed to one proton in NH.  Thirdly, the ILVs are well distributed 
along LcrG (Figure 5-5B), and since hydrophobic interaction is an important component of 
protein-protein interactions, mapping the effects on 13C-methyl labeled ILV will identify the 
binding interface.  The methyl resonances of Ile, Leu, and Val of LcrG7-73 C34S are indicated in 
the 2D 1H-13C HSQC spectrum of 13C ILV-LcrG7-73 C34S (Figure 5-5A).  The 13C methyl 
resonances of Ile and Val of 13C ILV-LcrG7-73 C34S were assigned by mutagenesis.  The 
isoleucines (Ile-20, Ile-37, Ile-47, Ile-56 and Ile-67) and valine (Val-44) of LcrG were serially 
mutated to alanine, and 2D 1H-13C HSQC spectra were acquired for each mutant.  The 2D 1H-13C 
HSQC spectrum of each mutant was superimposed with the spectrum of the wild type protein to 
identify the peak that had disappeared (Figure 5-6).  For example in Figure 5-6A, it can be 
clearly seen that a peak disappeared (shown by an arrow) upon superimposition of the two 
HSQC spectra (13C ILE-LcrG7-73 C34S in black and 13C ILE-LcrG7-73 C34S I37A in red) thus 
identifying that peak as belonging to Ile-37.  With this approach, the 13C methyl side chains of all 
five isoleucines and one valine residue were assigned (Figure 5-6).  The methyl side chains of 
Ile-20 and Ile-67 were overlapped (Figure 5-6).  However, this approach of mutagenesis is not 
amenable for assigning the methyl resonances of leucine because of the significant number of 
overlapping peaks.  Nevertheless, Ile and Val assignments were used to identify the residues of 
LcrG that were perturbed upon binding to LcrV.   
NMR titrations were performed using purified 13C ILV-LcrG7-73 C34S mixed with increasing 
amounts of unlabeled LcrV.  Two-dimensional 1H-13C HSQC spectra were acquired at each 
LcrG:LcrV molar ratios (0.0, 0.25, 0.5, 1.0 and 2.0) and the spectra were overlayed (Figure 5-7) 
to monitor the changes in the HSQC spectra of 13C ILV-LcrG7-73 C34S upon binding to LcrV.   
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Figure 5-6.  Overlaid 2D 1H-13C HSQC spectra of 13C ILE-LcrG7-73 C34S (WT) in black with 
(A) I37A in red (B) I47A in red (C) I20A in red (D) I56A in red (E) I67A in red.  Overlaid 2D 
spectrum of 13C LV (leucine and valine) LcrG7-73 C34S (WT) in black with (F) V44A in red.  
(G) 2D 1H-13C HSQC spectrum of 13C ILE-LcrG7-73 C34S showing all the assigned isoleucines, 
with the residue names next to the corresponding peaks.  (H) 2D 1H-13C HSQC spectrum of 13C 
LV-LcrG7-73 C34S showing the assigned valine residue. 
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Figure 5-7.  Five overlaid 2D 1H-13C HSQC spectra of  (A) 13C ILE-LcrG7-73 C34S (isoleucine 
spectrum) and (B) 13C LV-LcrG7-73 C34S (leucine and valine spectrum) with increasing molar 
ratios of LcrV.  Residues that showed reduction in peak intensities are indicated with asterisks.  
Peaks that appeared in new positions on complex formation are shown in boxes.  The names of 
the isoleucines and valine residues are indicated next to their corresponding peaks. 
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All the five isoleucines (Ile-20, Ile-37, Ile-47, Ile-56 and Ile-67) and one valine (Val-44) showed 
reduction in peak intensities (Figure 5-7) upon complex formation with LcrV.  Additionally, 
new peaks appeared in the Ile methyl region which, according to the 15N titration data (discussed 
in section 5.2.2), was expected to lie in the region of residues Ser-52 to Arg-73.  Two isoleucine 
residues, Ile-56 and Ile-67, were present in this region.  Therefore, the two new peaks that 
appeared upon complex formation in the 13C ILE-LcrG7-73 C34S spectrum may possibly belong 
to Ile-56 and Ile-67.  The complex peaks are labeled as Ile-156/Ile-167 in Figure 5-7A. 
5.2.4 Mutational analysis of the Ser-52 to Arg-73 region of LcrG in Yersinia pestis 
Based on the observation from the NMR titration experiments that residues from Ser-52 to Arg-
73 of LcrG were perturbed upon complex formation with LcrV, a “Yop secretion assay” was 
used to evaluate the functional significance of this region in Y. pestis.  This work was done in 
collaboration with Dr. Gregory V. Plano (University of Miami).  Several point mutants and 
deletion mutants of LcrG were constructed in this region.  These mutants were introduced in the 
pBAD vector in LcrG C34S background and expressed in Y. pestis.  The ability of these mutants 
to control secretion of the effector protein YopM was tested by the Yersinia Yop secretion assay 
described in section 2.4.  Four mini deletion mutants (Δ52-57, Δ58-62, Δ63-67 and Δ68-73) and 
a mutant with a deletion of the entire region (Δ52-73) were constructed.  In addition to these 
deletion mutants, nine point mutants (I56N, K57E, K57L, R61E, R61L, I67N, K68E, K68L and 
L63N) were also constructed.  The details of the mutants can be found in Table 2.  
Based on the helical nature of the C-terminus of LcrG from the NMR secondary chemical shifts 
(Figure 4-10 in Chapter 4), a helical wheel of the region Ser-52 to Arg-73 was done.  The helical 
wheel of Ser-52 to Arg-73  (Figure 5-8) showed that residues Ile-56, Leu-63 and Ile-67 of LcrG  
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Figure 5-8.  Helical wheel projection of the region Ser-52 to Arg-73 in LcrG.  The hydrophobic 
residues are in yellow, the uncharged polar residues are in blue, the positively and the negatively 
charged polar residues are in green and pink respectively, and proline is in red.  The orange 
asterisks indicate a hydrophobic patch and the green asterisks indicate a polar patch.  These 
residues indicated with asterisks were chosen for mutation 
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Figure 5-9.  Mutational analysis of the Ser-52 to Arg-73 region of LcrG in Y. pestis.  All the 
point mutants (except LcrG L63N) and one deletion mutant Δ68-73 behaved as wild type LcrG. 
The point mutant LcrG L63N and the deletion mutants Δ52-73, Δ52-57, Δ58-62 and Δ63-67 
were defective in secretion blocking activity of LcrG and hence constitutively secreted YopM 
both in the presence and absence of Ca+2.  The ΔlcrG represents a non-functional deletion mutant 
of LcrG (Δ39-54), and hence the lower bands are seen in the whole cell blot of ΔlcrG.  All the 
mutants, except Δ52-73 and L63N showed normal expression of LcrG. 
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Table 2.  List of the point mutants and the deletion mutants of the region Ser-52 to Arg-73 in 
LcrG, along with the rationale for creating them.  Results of the Yop secretion assay are also 
shown. 
Point Mutants Rationale Effect on secretion of the effector YopM  
1. L63N Non-polar to polar Defective.  Constitutively secreted YopM in presence and absence of Ca+2. 
2. I56N Non-polar to polar Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
3. I67N Non-polar to polar Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
4. K57E Charge reversal Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
5. K57L Polar to non-polar Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
6. K68E Charge reversal Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
7. K68L Polar to non-polar Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
8. R61E Charge reversal Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
9. R61L Polar to non-polar Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
Deletion mutants 
Δ52-73 Defective.  Constitutively secreted YopM in presence and absence of Ca+2. 
Δ52-57 Defective.  Constitutively secreted YopM in presence and absence of Ca+2. 
Δ58-62 Defective.  Constitutively secreted YopM in presence and absence of Ca+2. 
Δ63-67 Defective.  Constitutively secreted YopM in presence and absence of Ca+2. 
Δ68-73 Behaved as wild type.  Secretion of YopM only in the absence of Ca+2. 
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formed a hydrophobic patch, and residues Lys-57, Arg-61 and Lys-68 formed a hydrophilic 
patch.  The hydrophobic and the charged nature of these residues were conserved among all the 
homologous species (Figure 4-2A in Chapter 4).  The mutations were designed to alter a 
hydrophobic amino acid to a polar amino acid, a charged amino acid to its opposite charge, and 
to a hydrophobic amino acid (Table 2).  Results of the Yop secretion assay show that the 
deletion mutants, Δ52-73, Δ52-57, Δ58-62, and Δ63-67 were all defective in LcrG dependent 
regulation of YopM secretion, and hence they constitutively secreted YopM both in the presence 
and absence of Ca+2 (Figure 5-9).  However, the deletion mutant, Δ68-73 behaved as wild type 
and secreted YopM only in the absence of Ca+2 (Figure 5-9).  Similarly, all the point mutants 
except L63N behaved as wild type.  The mutant L63N showed a defect in LcrG dependent 
regulation of YopM secretion, and hence constitutively secreted YopM (Figure 5-9).  The results 
of the Yop secretion assay are summarized in Table 2.  The levels of YopM and LcrG in the 
whole cells were analyzed in all the constructs by blotting with antibodies.  Except for the LcrG 
Δ52-73 and L63N mutants, all the mutants showed normal expression of LcrG. 
5.2.5 NMR Titration using 13C ILE-LcrV 
To confirm whether the coiled coil domain of LcrV was involved in the interaction with LcrG, 
NMR titrations were carried out using labeled tip protein, LcrV combined with increasing 
amounts of unlabeled chaperone, LcrG7-73 C34S.  The positions of the methyl groups of Ile, Leu 
and Val of LcrV are indicated in the 2D 1H-13C HSQC spectrum of 13C ILV-LcrV (Figure 5-
10A).  The Ile, Leu, and Val are very well distributed along the structure of LcrV (Figure 5-
10B).  Since the methyl groups of Ile (shown as red spheres in Figure 5-10B) are also well 
distributed along the structure of LcrV, 13C ILE-LcrV was used for the NMR titrations.  2D 1H-
13C HSQC spectra were acquired for each LcrV:LcrG molar ratio (0.0, 0.25, 0.5, 1.0 and 2.0) and  
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Figure 5-10.  (A) Two-dimensional 1H-13C HSQC spectrum of LcrV where the positions of the 
13C methyl groups of Ile, Leu and Val are boxed.  (B) Structure of LcrV showing the distribution 
of Ile (red), Val (blue) and Leu (Magenta).  The number of ILVs in the structure are indicated. 
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Figure 5-11.  Two overlaid 2D 1H-13C HSQC spectra of 13C ILE-LcrV in complex with (A) 
LcrG7-73 C34S and (B) LcrGFL C34S in a 1:1 molar ratio.  New peaks and the peaks which 
decreased in intensity on complex formation, are indicated with boxes and asterisks, 
respectively.  The inset in B represents an expanded view of the blank box to show the presence 
of the complex peak that is present at a lower contour level compared to the rest of the peaks.  
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Figure 5-12.  (A) Two overlaid 2D 1H-13C HSQC spectra of 13C ILE-LcrV (black) with 13C ILE-
LcrV I206A (blue).  The arrow shows the assignment of I206.  (B) Two-dimensional 1H-13C 
HSQC spectrum of 13C ILE-LcrV showing the assignments for the isoleucines.  Residue names 
are labeled next to their corresponding peaks. 
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the spectra were overlayed.  Similar titrations were repeated using 13C ILE-LcrV combined with 
increasing amounts of unlabeled LcrGFL C34S.  For comparison of the two sets of titrations, only 
the spectra acquired with the complex at molar ratios of 0.0 and 1.0 are shown for clarity (Figure 
5-11).  The same set of Ile residues of LcrV were perturbed on binding to both LcrG7-73 C34S 
and LcrGFL C34S.  In both cases, there were four peaks that appeared in new positions (boxed in 
Figure 5-11), and same peaks that underwent significant reduction in intensities (marked with 
asterisks) (Figure 5-11).  Thus, we could conclude that both truncated LcrG (LcrG7-73 C34S) and 
the full-length LcrG (LcrGFL C34S) bind similarly to LcrV.    
To assign the 13C methyl resonances of isoleucines in LcrV, a similar mutational approach as 
described in section 5.2.2 was followed.  The 13C methyl side chains of the five isoleucines (Ile-
206, Ile-294, Ile-302, Ile-233 and Ile-135) of LcrV were assigned (Figure 5-12B).  An example 
of the mutagenesis method used in assigning LcrV Ile-206 is shown in Figure 5-12A.  Upon 
mapping the NMR titration data to the crystal structure of LcrV (Chapter 3), it was seen that Ile-
302 and Ile-294 which were perturbed on binding to LcrG, both lie in the coiled coil domain of 
LcrV (Figure 5-13).  Ile-135 of LcrV, which also showed significant decrease in peak intensity 
upon complex formation, is located in helix α-6, which makes a close contact with helix α-12 of 
the coiled coil.  The residue Ile-206, which lies in the mixed α/β domain of LcrV, was not 
perturbed upon binding to LcrG.  However, Ile-233 that is present in a loop in the mixed α/β 
domain of LcrV was perturbed to some extent upon titration of LcrG.  
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Figure 5-13.  (A) Five overlaid 2D 1H-13C HSQC spectra of 13C ILE-LcrV titrated with 
increasing molar ratios of LcrG7-73 C34S.  Peaks that showed reduction in intensities are 
indicated with asterisks.  Peaks that appeared in new positions upon complex formation are 
boxed.  The assignments of isoleucine residues are indicated.  (B) Crystal structure of LcrV 
(obtained as described in Chapter 3) shown with the positions of the assigned isoleucines. The 
isoleucines that were highly perturbed on binding are shown as red spheres, the one slightly 
perturbed is shown as an orange sphere, and the one that remains unpertubed is shown as a 
yellow sphere.  
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5.3 Discussion 
5.3.1 LcrG and LcrV form a tight complex   
LcrG7-73 C34S eluted at the position of a trimer (22 kDa) through the SEC column (Figure 5-1).  
The low temperature (4° C) at which the SEC column was run probably contributed to LcrG 
aggregation.  It is possible that the aggregated form of LcrG is physiologically relevant, and may 
be required for its stabilization.  The observed SEC peak corresponding to the complex however, 
roughly equals the molecular weight of an LcrG-LcrV heterodimer.  This suggested that in the 
presence of LcrV, the LcrG trimer dissociates to form an LcrG-LcrV heterodimer.  Since, LcrG 
and LcrV co-migrated in gel filtration (Figure 5-1), this suggested that they form a high-affinity 
complex.  Additionally, the interaction between LcrG and LcrV was in the slow exchange NMR 
time scale, indicating a tight binding interaction (Figures 5-2, 5-3 and 5-7).  This is in 
agreement with the nanomolar binding affinity of the LcrG-LcrV complex as reported by Lawton 
et al. (4).  
Unfortunately, attempts to obtain a Kd to quantify the binding were not successful using either 
surface plasmon resonance (SPR) or florescence polarization (FP) which were carried out 
according to the protocols described in sections 2.7 and 2.8.  For SPR, a clear binding response 
curve was not observed, and this is possibly due to the degradation of LcrG upon immobilization 
on the CM5 chip used in SPR.  On the other hand, the poor labeling efficiency of LcrG with the 
fluorescent dye (F5M) impeded FP experiments.  Due to the dynamic nature of LcrG, the solvent 
accessibility of the native cysteine residue could not be ascertained, and this probably 
contributed to the poor labeling efficiency. 
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5.3.2 LcrG is perturbed along the entire length upon binding to LcrV 
NMR titrations using 15N LcrG7-73 C34S indicated that LcrV induced a global change in the 
structure of LcrG upon binding.  LcrG residues Asp-7 to Arg-51 showed significant reduction in 
peak intensities (intermediate exchange), whereas the residues Ser-52 to Arg-73 appeared as 
peaks in new positions (slow exchange) upon complex formation (Figure 5-2 and Figure 5-3).  
This meant that LcrG is perturbed along the entire length upon binding to LcrV.  This 
observation is further supported by NMR titrations using 13C ILV-LcrG7-73 C34S (Figure 5-7).  
On one hand, our data agrees with the published results that showed that the N-terminus of LcrG 
is the binding site for LcrV (2, 3).  On the other hand, NMR titrations shown here also indicated 
that the C-terminus of LcrG is perturbed upon binding.  Thus, it is possible that the sheer 
difference in size between the two binding partners (37 kDa for LcrV and 8 kDa for LcrG) 
entails that almost the full length of the smaller protein (LcrG) is needed to form a stable binding 
interface.  Since LcrG is partially folded and intrinsically flexible, it is highly likely that LcrG 
wraps around LcrV.  This is not uncommon since many flexible proteins present a larger surface 
area for interaction as compared to globular proteins (9).  The data presented here does not 
indicate that the interhelical contacts within LcrG become tighter on complex formation, as that 
would result in an increase in the backbone amide proton chemical shift range of the 15N LcrG7-73 
C34S HSQC spectrum upon binding to LcrV. 
5.3.3 Ser-52 to Ile-67 of LcrG is important for blocking the Y. pestis T3SS 
The N-terminal region of LcrG has been shown to interact with LcrV by yeast two-hybrid assays 
(3).  Mutational analysis of the N-terminus of LcrG identified a mutant, A16R that could block 
the secretion of Yop effectors (2, 3).  Results of NMR titrations shown here indicated that both 
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the N and the C-termini of LcrG were affected upon binding to LcrV.  Through collaboration 
with Dr. Gregory V. Plano (University of Miami), the biological significance of the C-terminal 
region (Ser-52 to Arg-73) of LcrG was evaluated by a Yop secretion assay in Y. pestis.  Several 
LcrG point and deletion mutants were constructed and the ability of these mutants to control the 
secretion of Yop effector (YopM) was tested (Figure 5-9).  Interestingly, all the deletion mutants 
(Δ52-57, Δ58-62, Δ63-67, and Δ52-73) and the one point mutant, L63N, showed defects in the 
secretion blocking activity of LcrG (Figure 5-9).  The rest of the point mutants and one deletion 
mutant, Δ68-73, behaved as wild type LcrG.  Since all the mutants showed expression of LcrG, it 
was concluded that the secretion blocking activity is not an artifact of the LcrG protein level, 
which was observed with Δ52-73 and L63N.  NMR results plus the results of the Yop secretion 
assay suggested that the region Ser-52 to Ile-67 in LcrG plays an important role in blocking the 
secretion of Yops.  Preliminary results of Matson and coworkers (3) suggested that the C-
terminus of LcrG, in particular residue Phe-48, is involved in blocking the secretion of Yops.  
The NMR and the results of the Yop secretion assay shown here are further corroborated by 
results on the homolog, PcrG, which also implicated that the C-terminus is important in blocking 
the secretion of effector proteins (10).  Thus, to connect the NMR titration data with the results 
from the Yop secretion assay; the C-terminus of LcrG (52-73) was suggested to be the site of 
tight binding as indicated by the slow exchange peaks, and the region 52-67 in LcrG was shown 
to be important in blocking the secretion of Yops.  Hence it is highly likely, that the LcrV 
binding and secretion blocking regions in LcrG overlap, and so none of the mutants could block 
secretion of YopM.   
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5.3.4 The coiled coil domain of LcrV is perturbed upon binding to LcrG 
Since LcrV is a rather large protein (326 residues), assigning each backbone amide peak for 
uniformly labeled 15N LcrV to identify the residues perturbed upon complex formation is time 
consuming.  However, the presence of a number of isoleucines in the primary amino acid 
sequence of LcrV, which are well distributed throughout its length offered an amenable way in 
mapping the binding region.  Thus, NMR titrations using 13C ILE-LcrV and unlabeled LcrG7-73 
C34S were carried out, and the results indicated that the coiled coil domain of LcrV is perturbed 
upon binding to LcrG.  The isoleucine residues of LcrV, Ile-294, Ile-302, and Ile -135 that were 
perturbed on binding to LcrG lie on the same surface of LcrV (Figure 5-13).  The residues Ile-
294 and Ile-302 lie in the longer helix α-12 that forms part of the coiled coil in LcrV.  The 
residue Ile-135 lies in the helix α-6 of LcrV that is in close contact with the coiled coil (Figure 
5-13B).  However, the perturbation observed in the LcrV residue Ile-233 (located in a loop of the 
mixed α/β domain) on binding to LcrG could be an indirect effect of the interaction.  Overall, 
these data suggest that the coiled coil region of LcrV is perturbed on binding to LcrG, in 
agreement with previous reports (4, 5). 
In summary, it is shown by NMR spectroscopy that LcrV induced a global change in the 
structure of LcrG upon complex formation, and the LcrV coiled coil domain is important in 
binding to LcrG.  The results of the Yop secretion assay indicated LcrG Ser-52 to Ile-67 plays an 
important role in blocking the Yersinia pestis T3SS.
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CHAPTER 6: Structural studies on PcrG and PcrG-PcrV interaction from the type III 
secretion system of Pseudomonas aeruginosa 
6.1 Introduction 
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen that is most frequently 
associated with nosocomial infections in patients with cystic fibrosis, pneumonia, AIDS, cancer, 
or other ailments that compromise the immune system (1).  Despite treatment with potent 
antibiotics, the mortality rate is approximately 40% in case of incidences of acute infection (2).  
To initiate infection, the bacterium deploys the type III secretion system (T3SS) to inject effector 
proteins into host cells (3) in order to modulate host cell biology for the benefit and survival of 
the bacterium (4, 5).  The two proteins that play critical roles in the assembly and regulation of 
type III secretion in P. aeruginosa are the tip protein, PcrV (6) and its chaperone, PcrG (7, 8). 
Secretion of effector proteins by the T3SS in P. aeruginosa is tightly regulated and is triggered 
by either host cell contact or depletion of Ca+2 (5).  Deletion of genes encoding either PcrG or 
PcrV results in the loss of regulation of effector secretion leading to constitutive secretion of 
effectors (8).  Multiple results confirm that PcrG and PcrV interact directly (8-10).  Remarkably, 
control of effector secretion was seen to be maintained in the case of a point mutation, V16R, 
which disrupts PcrG-PcrV binding (8).  However, this mode of secretion regulation is different 
from its homolog, LcrG of Yersinia pestis (11, 12).  PcrG helps to facilitate PcrV secretion (8).  
PcrG also helps in directing the translocation of effector proteins into the host cell (7).   
Following the investigations on the Yersinia tip protein chaperone LcrG reported in chapters 4 
and 5, another question remains unanswered: whether the structural disorder that was observed 
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for LcrG is a hallmark of members of the V-tip chaperone family, or whether it is typical of 
LcrG alone.  Accordingly PcrG, which shares sequence and functional homology to LcrG was 
chosen for a similar NMR-based structural characterization.  Results of NMR and CD 
spectroscopy show that PcrG, like LcrG, adopts a partially folded α-helical structure instead of 
forming a tightly packed coiled coil.  Additionally, PcrG and PcrV were shown to bind tightly 
with a nanomolar binding affinity, confirming the results of Nanao et al. (9).  NMR 
characterization of the PcrG-PcrV binding was in agreement with the LcrG-LcrV binding 
interaction, showing PcrV induced a global change on PcrG structure upon complex formation. 
6.2 Results 
6.2.1 Defining a PcrG construct for NMR characterization 
NMR data using 15N-labeled full-length PcrG (PcrGFL, 98 amino acids) yielded an NMR 
spectrum (Figure 6-3A) where the peaks were not well resolved and were overlapped. This 
could be due to the presence of disordered regions in PcrG.  To design a PcrG construct that will 
yield an ideal NMR spectrum, the program PSIPRED (13) was used to predict the secondary 
structure of PcrG (Figure 6-1B).  The extreme N and C termini of PcrG were predicted by 
PSIPRED to be random coils (Figure 6-1B).  To remove the disordered terminal residues and 
include the structured regions of PcrG while maintaining the hydrophilic terminal residues for 
solubility, a PcrG truncation was subcloned with residues Glu-9 to Ser-76 (PcrG9-76) fused to a 
C-terminal His6-tagged GB1 domain.  
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Figure 6-1.  Multiple sequence alignment (MSA) of PcrG (UNIPROT ID: Q9I326_PSEAE) 
family of tip chaperones and secondary structure prediction for PcrG.  (A) MSA of PcrG family 
of proteins using CLUSTALW.  The homologous proteins were obtained from BLAST and 
denoted as PcrG2 (different strain of P. aeruginosa), LcrG1 (Y. pestis), LcrG2 (Y. 
enterocolitica), AcrG1 (A. hydrophila) and LssG (P. luminescens).  The red line denotes the 
region homologous to the reported binding domain of LcrV on LcrG (14).  The blue line denotes 
the region homologous to the C-terminus of LcrG, which was perturbed upon binding to LcrV by 
NMR studies (Chapter 5).  (B) Result of secondary structure prediction for PcrG  by PSIPRED 
(13).  “C” or “H” denotes residues in random coil or helical regions, respectively.  A cartoon 
representation is also provided where the helices and random coils are represented as pink 
cylinders and black lines respectively.  
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6.2.2 Protein Expression and Purification   
Both the PcrG constructs (PcrGFL and PcrG9-76) and PcrV (the design of the PcrV construct is 
discussed in section 2.1.4) were overexpressed in E. coli and purified under native conditions by 
Ni2+-affinity chromatography.  Purified fractions were then cleaved by a His6-tagged TEV 
protease and products were loaded onto a Ni2+-affinity column to separate PcrGFL, PcrG9-76 or 
PcrV from the GB1 tag.  All the purified proteins produced yields in milligram quantities that 
facilitated NMR studies.  
6.2.3 Circular Dichroism and Thermal Denaturation 
Circular dichroism (CD) spectra of PcrGFL and PcrG9-76 showed alpha helical content based on 
the minima at 222nm and a significant amount of disorder based on the predominant minima at 
208nm.  Nevertheless, comparison of the two CD spectra (Figure 6-2A) confirmed that PcrGFL 
and PcrG9-76 have nearly identical secondary structures because their CD spectra were nearly 
superimposable.  Thus the PcrG9-76 truncation did not produce any appreciable changes to the 
secondary structure of PcrG.  The thermal denaturation curves of PcrGFL and PcrG9-76 (Figure 6-
2B) showed that they unfolded in a non-cooperative manner without showing any clear inflection 
points. 
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Figure 6-2.  CD and thermal denaturation spectra of the PcrG constructs.  (A) CD spectra 
acquired at 25° C for PcrGFL and PcrG9-76.  (B) Thermal denaturation plots of PcrGFL and PcrG9-
76.  (Molar ellipticity θ = (deg·cm2·dmol-1) × 10-5).  
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6.2.4 PcrG NMR spectra and backbone assignments 
PcrGFL and PcrG9-76 were soluble at high concentrations and afforded millimolar amounts of 
purified protein.  The 2D 1H-15N HSQC spectrum for PcrGFL (Figure 6-3A) showed a non-ideal 
NMR spectrum with broad and overlapped peaks, with many more peaks expected from a 98-
residue protein.  On the other hand, the PcrG9-76 truncation afforded a spectrum suitable for 
NMR characterization based on the presence of sharp and well-resolved peaks (Figure 6-3B).  
Hence 3D NMR datasets were acquired on PcrG9-76 to assign the backbone resonances of PcrG9-
76.  The two-dimensional 1H-15N HSQC spectrum of PcrG9-76 was assigned with the correct 
number of peaks expected for a 68-residue protein using the 3D HNCACB experiment.  The 
backbone amides of the 67 non-proline residues of PcrG9-76 were assigned as well as all 8 
residues of the C-terminal cloning artifact GSENLYFQ (Figure 6-4).  The overlapping peaks are 
indicated in the figure with asterisks (Figure 6-4).  Examples of the carbon backbone 
connectivity of some of the representative PcrG residues are illustrated in Figure 6-5. 
Analysis of the secondary Cα and Cβ chemical shifts suggested the presence of α-helices from 
residues Val-16 to Gly-41 and Glu-55 to Ser-76 (Figure 6-6A, B) with short interspersed 
residues with low helical content and few lack any apparent secondary structure.   
6.2.5 PcrG Backbone dynamics 
To assess the backbone dynamics of PcrG, the steady state heteronuclear {1H}-15N NOE and 15N 
backbone R1 and R2 relaxation rates for PcrG9-76 were acquired.    
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Figure 6-3.  2D 1H-15N HSQC spectra of (A) PcrGFL and (B) truncated PcrG9-76. 
 128 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 6-4.  Assigned 2D 1H-15N HSQC spectrum of PcrG9-76.  Residues are indicated next to 
their corresponding peaks.  Overlapped peaks are indicated with asterisks (L50* overlapped with 
L21 and F83; R13* overlapped with L33; and E48* overlapped with L70; D10* overlapped with 
E79; E69* overlapped with R74; E57* overlapped with R56 and R29; A14* overlapped with 
R24; M36* overlapped with Q38.  W37* was not well resolved).  The W37 side chain peak is 
not shown.  Residues 77-84 (G77SENLYFQ84) are cloning artifacts.  
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Figure 6-5.  Representative strips of the 3D HNCACB spectrum of 15N/13C PcrG9-76 spanning 
residues E9 to E20 (top) and L21 to I32 (bottom) to illustrate the backbone connectivity 
identified for PcrG9-76.
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Figure 6-6.  (A) Cα and (B) Cβ secondary chemical shifts of PcrG9-76 suggested the presence of 
two α-helical regions.  If the Cα chemical shifts are consistently positive, it is denoted as a α-
helix.  The positions of the helices are indicated.  The random coil chemical shifts are determined 
as described in Chapter 2 (section 2.3.3).  
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The heteronuclear {1H}-15N NOE provides insight into the backbone dynamics of proteins at 
picoseconds to nanoseconds time scales.  Heteronuclear {1H}-15N NOE values above 0. 6 
indicate well-structured regions and can be qualitatively described as being rigid.  Heteronuclear 
{1H}-15N NOE values between 0.4-0.6 can be qualitatively described as semi-rigid flexibility, 
whereas, {1H}-15N NOE values below 0.2 indicate completely unstructured regions, as in 
random coils.  Most of the residues in the two α-helices showed {1H}-15N NOEs between 0.4 to 
0.6 (Figure 6-7A).  The {1H}-15N NOEs of residues outside of these two helices were mostly at 
or below 0.4 except a few of them were above 0.4.  Only one residue (Leu-12) had a {1H}-15N 
NOE of slightly below 0. 2 indicating random coil flexibility.  Interestingly, some residues 
within the two helices showed {1H}-15N NOEs values above 0. 6.   
The 15N backbone relaxation rates (R1 and R2) indicated that the two helices in PcrG behaved 
with nearly similar backbone amide dynamics (Figure 6-7B, C).  For both the datasets, there was 
no appreciable difference in the relaxation rates from the beginning to the end of the protein.  
This indicated that PcrG tumbles as a single entity in solution, as opposed to, for example, helix 
α1 tumbling at a different rate compared to helix α2.  The gaps in the datasets are due to the 
overlapping peaks that have been omitted from the analyses.  
6.2.6 NMR titrations with 15N PcrG9-76 
NMR chemical shift mapping was used to characterize the PcrG-PcrV interaction.  Purified 15N-
labeled PcrG9-76 was titrated with increasing amounts of PcrV (at PcrV:PcrG molar ratios of 0.0, 
0.25, 0.5, 1.0, 2.0 and 4.0) in NMR buffer. 
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Figure 6-7.  (A) Heteronuclear {1H}-15N NOEs, (B) R1 and (C) R2 relaxation data for PcrG9-76.  
The helical regions are shaded. 
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The changes were monitored by acquiring 2D 1H-15N HSQC spectra.  The 2D 1H-15N HSQC 
spectrum for each titration ratio was overlayed to determine the changes in the 1H-15N HSQC of 
PcrG as it binds to PcrV (Figure 6-8).  With the exception of only 7 of the 75 backbone amide 
peaks (including the C-terminal cloning artifact), nearly all peaks showed significant reduction in 
peak intensities with increasing molar ratios of PcrV.  The 7 peaks that did not show any change 
in peak intensities throughout the titration corresponded to the cloning artifact residues (Ser-78, 
Glu-79, Asn-80, Leu-81, Tyr-82, Gln-84) and one PcrG residue Leu-50.  However, one of the 
cloning artifact residues Gly-77 appeared to be in fast exchange time scale on titration with 
PcrV.   
6.2.7 NMR titrations with 13C-ILV PcrG9-76 
A second NMR titration was performed using purified 13C-ILV PcrG9-76 combined with 
increasing molar ratios of PcrV.  The advantages of the ILV labeling technique have been 
explained in section 5.2.3 (Chapter 5).  The positions of the methyl groups of Ile, Leu and Val 
(ILV) of PcrG9-76 are indicated in the two-dimensional 1H-13C HSQC spectrum of 13C ILV-
PcrG9-76 (Figure 6-9A).  The ILVs are well distributed throughout PcrG as shown in Figure 6-
9B.  2D 1H-13C HSQC spectra were acquired at each PcrV:PcrG molar ratio (0.0, 0.25, 0.5, 1.0, 
2.0, and 3.0) and then overlayed (Figure 6-10) to monitor the changes in the HSQC spectra of 
13C ILV-PcrG9-76 upon binding to PcrV.  As the concentration of PcrV increased, many peaks in 
PcrG were reduced in intensity (indicated by asterisks in Figure 6-10) upon binding to PcrV.    
To identify the residues of PcrG that were perturbed upon complex formation with PcrV, the 
mutational approach (described in section 5.2.3) was used to assign the methyl groups of ILVs.   
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Figure 6-8.  (A) Six overlaid 2D 1H-15N HSQC spectra of PcrG9-76 with increasing ratios of 
PcrV.  Assigned backbone amide peaks that remained unperturbed by the titration are labeled. 
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This approach was rather challenging for PcrG due to the significant number of overlapping 
peaks and conformational heterogeneity.  The methyl groups of Val-16, Ile-20, and Leu-66 could 
be assigned unambiguously.  These three residues underwent reduction in peak intensities upon 
binding to PcrV (Figure 6-10).  The presence of two peaks for Ile-20 and Val-16 indicated 
conformational heterogeneity of PcrG (Figure 6-10).  Interestingly only one conformation of Ile-
20 and Val-16 of PcrG were perturbed (indicated with asterisks) upon complex formation with 
PcrV.  Based on the NMR secondary chemical shift mapping, the residues Ile-20 and Val-16 lie 
in the helix α-1, and the residue Leu-66 lies in the helix α-2 of PcrG.  Thus, both the helices of 
PcrG were perturbed on binding to PcrV.  
6.2.8 NMR titrations with 13C-ILE PcrV 
Another set of titration experiments was carried out using 13C ILE-PcrV combined with 
increasing molar ratios of unlabeled PcrG9-76.  Similarly, 2D 1H-13C HSQC spectra were acquired 
at each PcrG:PcrV molar ratios (0.0, 0.5, 1.0, 2.0 and 3.0) and then superimposed.  This same set 
of titration experiments was also done with unlabeled PcrGFL.  For comparison of the results for 
PcrGFL and PcrG9-76, spectra from two molar ratios (0.0 and 1.0) are shown for clarity (Figure 6-
11).  In both the datasets (showing the PcrV isoleucines), there were two new peaks (shown as 
boxes) and two peaks that disappeared from the spectra (shown with arrows) upon complex 
formation (Figure 6-11).  Although the PcrV isoleucine spectrum is not assigned, the important 
point to note is that the same sets of PcrV residues were affected when titrated with PcrGFL or 
PcrG9-76.   
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Figure 6-9.  (A) Two-dimensional 1H-13C HSQC spectrum of 13C-ILV PcrG9-76 where the 
positions of the 13C methyl groups of Ile, Leu and Val are indicated.  (B) Amino acid sequence of 
PcrG9-76 showing the distribution of Ile (red), Leu (pink), and Val (blue). 
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Figure 6-10.  Six overlaid 2D 1H-13C HSQC spectra of (A) 13C- ILE PcrG9-76 and (B) 13C-LV 
(leucine and valine) PcrG9-76 with increasing ratios of PcrV.  Peaks that reduced in intensities are 
marked with asterisks.  The three assigned methyl groups of Ile-20, Val-16, and Leu-66 are 
indicated next to their peak positions. 
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Figure 6-11.  Two overlaid 2D 1H-13C HSQC spectra of 13C ILE-PcrV in complex with (A) 
PcrGFL and (B) PcrG9-76 in a 1:1 molar ratio.  New peaks, and the peaks, which decreased in 
intensity and disappeared from the spectra upon complex formation are indicated with boxes and 
arrows respectively.   
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Thus, both PcrGFL and PcrG9-76 bind similarly to PcrV.  In other words, the truncation did not 
alter the ability of PcrG to bind to PcrV.   
6.2.9 Surface Plasmon Resonance Spectroscopy 
Surface plasmon resonance (SPR) was used to determine the binding affinity and binding 
kinetics between PcrV and PcrG.  PcrG constructs were fused to a C-terminal GB1-His6 tag to 
facilitate immobilization to anti-His6 antibody coated CM5 flow cells.  Injection of PcrV into 
flow cells with immobilized PcrG produced a clear binding response that increased 
proportionally with increasing analyte concentration.  The SPR data for the interaction between 
PcrV and PcrGFL was best fitted to a 1:1 Langmuir model (χ2 = 0. 314) (Figure 6-12).  The Kd 
for this interaction was calculated to be 26.5 nM, which is very similar to that previously 
described by Nanao et al. (9) in which SPR was used to evaluate binding between full length 
proteins, PcrG and PcrV.  Thus, the N-terminal 24-residue truncation of PcrV had little effect on 
the interaction.  The binding also occurred with rapid kinetics, with ka = 5.62 × 105 M-1s-1 and kd 
= 1.53 × 10-2 s-1.  
The truncations made in PcrG9-76 did not appear to have a significant effect in its PcrV binding 
capacity.  In fact, the sensorgram for PcrV binding to immobilized PcrG9-76-GB1-His6 was fit to 
a 1:1 Langmuir model (15) (χ2 = 2.53) and the calculated binding affinity was slightly higher 
than that for PcrGFL (23.7 nM) (Figure 6-12).  Also, the binding kinetics were found to be more 
rapid than seen for PcrGFL, though less than an order of magnitude, with ka = 1.02 × 106 M-1s-1 
and kd = 2.42 × 10-2 s-1.  These minimal changes in binding suggested that truncated PcrG9-76 
retained the regions needed for interaction with PcrV.   
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Figure 6-12. SPR sensorgrams for PcrV binding to (A) PcrGFL-GB1-His6, (B) PcrG9-76-GB1-
His6, and (C) GB1-His6 fusion tag. 
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The SPR data is consistent with the NMR titration experiment using 13C ILE-PcrV, which 
showed that both the truncated and full length PcrG bind similarly to PcrV.  
To account for possible interference of the GB1-His6 tag with the PcrG-PcrV interaction, a 
control sensorgram was collected with identical conditions from the previous experiment, but 
with GB1-His6 as the ligand (Figure 6-12).  The binding response to PcrV was insignificant and 
did not increase with increasing PcrV concentration.  Therefore, the GB1-His6 tag remained inert 
in the interaction.  This observation also pointed to the specificity of the PcrG-PcrV interaction.  
6.3 Discussion 
LcrG is the most closely related homolog of PcrG and shares with it a 41% sequence identity 
(Figure 6-1A).  Results of yeast two-hybrid suggested that the LcrG N-terminal residues, Asp7 
to Thr-40 (corresponding to Asp-10 to Ala-43 in PcrG), are required for LcrV interaction (14).  
The results of the NMR titrations (Chapter 5) suggested that the C-terminus of LcrG from 
residues Ser-52 to Arg-73 (corresponding to Glu-55 to Ser-76 in PcrG) was also perturbed upon 
complex formation with LcrV (Chapter 5).  While in vivo substitutions of PcrG for LcrG in Y. 
pestis have been unable to transcomplement normal T3SS regulation, both proteins bind LcrV 
(14).  Thus, PcrG likely maintains the LcrG binding motif for its respective adaptor protein, 
PcrV.   
6.3.1 PcrG is a partially folded protein 
Due to the non-ideal NMR spectrum of PcrGFL, a PcrG truncation (PcrG9-76) was constructed for 
NMR studies.  The use of truncated PcrG was validated with different experimental approaches, 
and results show that both the full length and truncated PcrG behaved similarly with respect to 
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binding PcrV.  CD spectroscopy showed that both PcrG9-76 and PcrGFL spectra maintained 
similar ratios of the composition of secondary structure (Figure 6-2).  Results from SPR 
confirmed that the PcrG truncation showed similar binding affinity and binding kinetics for PcrV 
(Figure 6-12).  In fact, the binding affinity was slightly higher than that of PcrGFL, which might 
be attributed to the removal of non-participating residues that may otherwise reduce binding 
accessibility.  GB1-His6 fusion proteins were used for SPR studies because anti-polyhistidine 
antibodies were used to coat the surface of the flow cells by amine coupling.  Another NMR 
titration using 13C ILE-PcrV showed that both PcrG9-76 and PcrGFL bind to the same surface of 
PcrV, as the same set of isoleucine residues were affected in PcrV upon titration with PcrG9-76 or 
PcrGFL (Figure 6-11).   
CD spectroscopy and thermal denaturation, which showed the absence of a clear melting 
temperature (Tm) (Figure 6-2), indicated that PcrG is a helical protein without any well-ordered 
tertiary structure.  Nanao et al. (9) also observed that PcrG does not display a clear Tm, which is 
consistent with our observation.  Additionally, the θ222/208 ratio of 0.7 is indicative of a partially 
folded helical protein with loosely packed helices.  The results of CD are consistent with the 
narrow proton chemical shift range (<1 ppm) of PcrG in the 2D 1H-15N HSQC spectra (Figure 6-
3) which suggested that the protein might be highly α-helical or unstructured.  Similarly, the 2D 
1H-13C HSQC spectrum of PcrG where the methyl groups of Ile, Leu and Val were labeled also 
showed poor chemical shift dispersion with conformational heterogeneity and broad overlapping 
peaks (Figure 6-9A).  This too is indicative of relatively loose packing of the hydrophobic 
regions in PcrG.  
For the NMR characterization of PcrG9-76, the full 2D 1H-15N HSQC spectrum of PcrG9-76 was 
assigned by 3D NMR experiments.  The secondary Cα and Cβ chemical shifts suggested that the 
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secondary structure of PcrG is essentially dominated by two α-helices (Figure 6-6).  The 
heteronuclear {1H}-15N NOE experiment showed that the helices do not form well-structured 
(rigid) regions, but instead have semi rigid flexibility (Figure 6-7A).  Interestingly, some of the 
residues in the helices have {1H}-15N NOEs above 0.6, which suggest they may have backbone 
dynamics approaching a well-structured state.  The residues that lie outside the helices have 
{1H}-15N NOEs at or below 0.4, suggesting higher flexibility in these regions.  The 15N 
backbone relaxation rates (R1 and R2) showed that the α-helices behaved with similar backbone 
dynamics and the whole protein tumbles as a single unit in solution (Figure 6-7B, C).  Thus 
overall, NMR data presented herein suggested that PcrG, like LcrG has secondary structure but 
lacks a compact tertiary structure, and hence can be best described as a partially folded helical 
protein.  
Direct binding between PcrG and PcrV has been demonstrated previously (9, 10), but a defined 
PcrV binding region on PcrG has yet to be identified.  The NMR titration experiments (Figure 6-
8, 6-10) using PcrG9-76 indicated that PcrV induced a global change in PcrG structure that may 
likely result from a combination of both PcrV-binding interactions and binding-induced 
conformational changes within PcrG.  As noted for LcrG-LcrV binding interaction in Chapter 5, 
the size difference between PcrV (33KDa) and PcrG9-76 (8KDa) makes the wrapping of PcrG 
around PcrV a likely scenario providing a large surface area for interaction and thus increasing 
the stability of the PcrG-PcrV complex.   
6.3.2 Significance of PcrG as a partially folded protein 
In conclusion, the NMR, CD, and SPR data presented here provided the first structural 
characterization of PcrG, showing that the PcrG chaperone family adopts a partially folded α-
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helical conformation lacking a compact tertiary structure.  Earlier results have pointed out 
multiple putative roles for PcrG towards control of secretion and translocation of effector 
proteins in P. aeruginosa T3SS (7, 8), as well as serving as a chaperone to the tip protein PcrV 
(7, 8).  The results showing an inherent structural flexibility for PcrG may aid in functional 
versatility of this protein, and is likely a hallmark of the PcrG/LcrG family of V-tip chaperones.  
Overall, the LcrG/PcrG family of proteins contributes to a growing list of partially folded 
proteins that play important roles in the bacterial type III secretion system.   
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CHAPTER 7: Summary 
The type III secretion system (T3SS) is utilized by a number of Gram-negative pathogenic 
bacteria to deliver effector proteins into the targeted host cells (1).  In addition to the structural 
proteins that form the needle apparatus, chaperones play many important roles in type III 
secretion (1).  These include stabilization of their binding partners in the cytoplasm, prevention 
of premature interactions with other partners, and facilitating secretion of the substrates (2, 3).  
These chaperones have been categorized into three classes depending on their T3SS substrates 
and these classes have been characterized structurally (4-6).  Class I chaperones help in 
maintaining the effector proteins in a secretion competent state (1).  Class II chaperones assist 
the hydrophobic translocators by neutralizing their toxicity while inside the bacterial cytoplasm 
(1).  Lastly, Class III chaperones prevent the premature polymerization of the needle protein 
inside the bacterial cytosol (1).  The T3SS tip proteins also require chaperones, but they have not 
been classified into any of the above three classes primarily because much less is known about 
their atomic structures.    
Comparison of the structures of T3SS tip proteins has highlighted the absence of the N-terminal 
α-helical hairpin domain in the structure of the V-tip proteins.  The N-terminal α-helical hairpin 
serves as a self-chaperone for the tip proteins IpaD and BipD (7).  It has been suggested that 
LcrG and PcrG form a coiled coil structure analogous to the self-chaperoning domains of the 
other tip proteins (7, 8).  However, the atomic structure of the LcrG/PcrG family of chaperones 
remains unknown.  The aim of the research presented in this dissertation was to fill this gap by 
gaining insight into the solution structure and dynamics of the V-tip chaperone family using 
NMR spectroscopy and other biophysical techniques. 
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Surprisingly and contrary to the earlier hypothesis proposed by others about LcrG/PcrG forming 
a coiled coil (7, 8), data presented here show that LcrG and PcrG lack a tertiary structure 
(Chapters 4 and 6).  The two-dimensional 1H-15N HSQC spectra of these chaperones displayed a 
narrow backbone proton chemical shift range (<1 ppm), which suggests that the protein is either 
highly α-helical or unstructured.  CD spectroscopy and thermal denaturation showed that these 
chaperones are α-helical but lack a distinct melting transition, which indicate the lack of a 
closely packed tertiary fold.  The molar ellipticity θ222/208 ratio of 0.7-0.8 obtained from the CD 
spectra of these chaperones is also indicative of a loosely packed helical protein.  Similarly, the 
2D 1H-13C HSQC spectrum of PcrG where the methyl groups of Ile, Leu and Val were 13C-
labeled also showed poor chemical shift dispersion with conformational heterogeneity and broad 
overlapping peaks.  This also indicates relatively loose packing of the hydrophobic regions in 
PcrG.  Secondary Cα and Cβ chemical shifts of the chaperones suggest that their secondary 
structures are dominated by two α-helices in PcrG, and three α-helices in LcrG.  Characterization 
of the backbone dynamics of the chaperones by heteronuclear {1H}-15N NOE suggests that the α-
helices display semi-rigid flexibility and do not form well-structured regions.  However, the 
presence of residues within the α-helical regions with {1H}-15N NOE values above 0.6 implies 
that although the chaperones lack a well-structured three-dimensional fold, they are not 
completely disordered but contain residues with flexibilities approaching a more stable 
conformation.  The 15N backbone relaxation rates (R1 and R2) suggested that the α-helices 
behave with nearly similar backbone amide dynamics with respect to each other, and they tumble 
as a single unit in solution.  Thus, the NMR and CD data presented here point towards the 
chaperones being highly α-helical, yet intrinsically flexible, and lacking a tertiary fold (Figure 4-
12). 
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The LcrG and PcrG chaperones are multifunctional.  In addition to facilitating the secretion of 
their respective tip proteins (9-11), they play important regulatory roles in the T3SS of Y. pestis 
and P. aeruginosa.  Both LcrG and PcrG serve as negative regulators of effector secretion (9, 10, 
12-15).  LcrG also plays a facilitative role in targeting Yop effectors into the host cells (11, 16).  
Likewise, PcrG also assists in the translocation of effector proteins into the host cells (17).  The 
conformational flexibilities of the chaperones perhaps contribute to their functional versatility, 
which is a characteristic feature of many flexible proteins (18, 19).  The conformationally 
interchangeable nature of intrinsically flexible structures like LcrG and PcrG ensures easier 
adaptation of distinct conformational states required for carrying out multiple roles within the 
cellular environment.   Disordered regions confer dynamic flexibility to proteins, allowing 
transitions between different conformations (20).  This increased flexibility is advantageous in 
the recognition of multiple binding targets (20).  It has been suggested that disordered proteins 
owing to a greater capture radius can associate faster with specific binding partners as compared 
to globular proteins with restricticted conformational freedom (19, 21).  Thus being partially 
folded proteins like the V-tip chaperone family can be particularly advantageous.  Such 
intrinsically disordered proteins are not only associated with transcriptional regulation, 
translation, and cellular signal transduction (22), but have also become common in the T3SS.  
They have been observed among effectors and structural proteins (6, 23).  The Salmonella inner 
rod protein PrgJ is an example of a partially folded α-helical protein (23).  Among other T3SS 
components that also display this kind of intrinsically flexible conformation are the Yersinia 
pseudotuberculosis effector protein YopE, and the Pseudomomas aeruginosa translocon proteins 
PopB and PopD (6, 24, 25).  
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NMR titrations using 15N LcrG7-73 C34S and 15N PcrG9-76 indicated that the V-tip proteins LcrV 
and PcrV induced a global change in the structure of their respective chaperones upon complex 
formation (Chapters 5 and 6).  LcrG residues Asp-7 to Arg-51 showed significant reduction in 
peak intensities, whereas the residues Ser-52 to Arg-73 appeared in new peak positions upon 
complex formation with LcrV.  Likewise, PcrG residues Glu-9 to Ser-76 also showed significant 
reduction in peak intensities upon binding to PcrV.  This suggests that the chaperones were 
perturbed along their entire length upon binding to the V-tip proteins.  In addition to the 
traditional 15N backbone labeling, 13C methyl labeling of the side chains of isoleucines, leucines 
and valines (ILV) of the chaperones were also used to map the binding interface.  The ILVs are 
well distributed along the chaperones and since hydrophobic interactions are an important 
component of protein-protein interactions, mapping the effects on 13C-methyl labeled ILV to 
identify the binding interface was a reasonable alternative.  NMR titrations using 13C ILV-LcrG7-
73 C34S and 13C ILV-PcrG9-76 further confirmed the observation that upon complex formation, 
the V-tip proteins induced a global change in the structure of the chaperones.  On one hand, this 
data agrees with the published results that showed the N-terminus of the chaperones is the 
binding site for the V-tip proteins (9, 12).  On the other hand, NMR titrations reported in this 
dissertation also indicated that the C-terminus of the chaperones is perturbed upon binding.  One 
likely explanation for this is that the sheer difference in size between the two binding partners 
(33-37 kDa for the V-tip proteins and 8 kDa for the chaperones) entails that almost the full 
length of the chaperones (LcrG and PcrG) is needed to form a stable binding interface.  This will 
not be uncommon since many flexible proteins present a larger surface area for interaction as 
compared to globular proteins (18).  It has also been confirmed by NMR spectroscopy that the 
coiled coil domain in LcrV is important in binding to LcrG. 
 151 
Examples of protein folding transitions are common in the T3SS.  The flexible regions of needle 
protomers become ordered upon needle assembly (26).  The Yersinia effector protein YopE 
undergoes a disorder-to-order transition upon complex formation with its chaperone, SycD (6).  
However, there is an example of the P. aeruginosa translocon protein PopD that remains in a 
molten globule like conformation, both in isolation and upon complex formation with its 
chaperone PcrH (25).  Data presented herein does not indicate any disorder-to-order transition of 
the chaperones upon complex formation with the tip proteins.  The interaction of the chaperones 
with their cognate tip proteins seems to discount the possibility of the chaperone-tip interaction 
being mediated by coiled coil domains (27), as the structure of neither LcrG nor PcrG becomes 
orderd upon binding.  If the interhelical contacts within the chaperones improved upon binding 
to their respective tip proteins it would have led to an increase in dispersion of the backbone 
proton chemical shift range of the 15N labeled HSQC spectrum of the chaperones upon titration 
with the tip proteins.  This kind of increased dispersion of the HSQC spectrum has been 
observed for a partially folded T3SS chaperone CesAB (from enteropathogenic Escherichia coli, 
EPEC) upon complex formation with the needle filament protein EspA (28), thereby indicating 
that CesAB folds upon binding to EspA.  But data presented here does not support any folding 
event of the V-tip chaperones upon binding to the tip proteins.  This may also have been one of 
the reasons due to which it was not possible to obtain a co-crystal of the LcrG-LcrV complex.  A 
future possibility could be to try co-overexpression of the tip protein and chaperone and test if 
that makes the structure of the complex more amenable to crystallization or structure 
determination by NMR.  Another exciting future possibility is to try and stabilize the dynamic 
conformation of the chaperones.  An example of stabilization of a molten globule like 
conformation of the T3SS chaperone, CesAB comes from the work of Chen et al. (28).  Chen et 
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al. (28) stabilized the partially folded conformation of CesAB by correcting the packing defects 
of the coiled coil of CesAB.  However, it would be important to verify whether the artificially 
stabilized chaperones remain functional in the T3SS.  Notably, if the chaperones lose 
functionality on stabilization it would be further proof that the flexibility of LcrG and PcrG is 
essential for its functionality.  In fact the artificially stabilized CesAB chaperone led to non-
functional T3SS (28), highlighting the importance of structural flexibility in achieving function.  
Additionally other chaperones from different T3SS systems have also been shown to adopt this 
kind of partially folded conformation (28), thereby providing additional support for the 
physiological relevance of proteins with highly dynamic confromations.   
Overall the results from the NMR titrations show that both the chaperones are perturbed along 
their entire length upon binding to the tip proteins.  More specifically, the NMR titrations using 
LcrG showed that the C-terminus of LcrG (Ser-52 to Arg-73) is highly perturbed upon binding to 
LcrV and this interaction is in slow exchange, which means tight binding.  On the other hand, the 
interaction with N-terminus of LcrG (Asp-7 to Arg-51) with LcrV is in intermediate exchange, 
which means weaker binding.  Thus, introspecting about the above results in plurality leads to a 
likely scenario where the entire length of the chaperones is involved in complex formation with 
the tip proteins, where the C-terminal half of LcrG binds more tightly to LcrV, while the N-
terminal half binds weakly to LcrV.  Due to the absence of the structure of the complex between 
the tip protein and chaperone, it is unclear exactly how the helices in the chaperones mediate 
protein-protein interactions with the coiled coil domain of LcrV.  The results of the Yop 
secretion assay (Chapter 5) suggest that the C-terminus of LcrG from residues Ser-52 to Ile-67 
plays an important role in blocking the secretion of Yop effectors.  This data is further 
corroborated by results on the homolog PcrG, which also indicate that the C-terminus of PcrG is 
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important in blocking the secretion of effectors (9).  Thus, our data suggests that the tip protein 
binding site and the secretion blocking site at the C-terminal region of LcrG overlap with each 
other.  However, studies with the homolog PcrG has shown that the tip protein binding and the 
secretion blocking activities can be separately attributed to the two halves of PcrG, though the 
full length of PcrG is needed for PcrV export (9).  The data presented here, indiactes that this 
might not be true for LcrG.  Further experiments are required to test this possibility, by creating 
more drastic mutants (such as three point mutations) in both the halves of LcrG, and testing them 
separately for their ability to bind LcrV and block effector secretion in Y. pestis.  This would lead 
to an overall understanding of how LcrG performs the dual activity of facilitating tip protein 
secretion and blocking secretion of effector proteins in Y. pestis. 
Since LcrG and PcrG have multiple roles in the T3SS, it is likely that they have multiple binding 
partners.  Characterization of the individual protein-protein interactions of these chaperones with 
the other components of the T3SS would improve the overall understanding of the regulation of 
effector secretion.  Since both the chaperones plug the T3SS from the cytoplasmic face, they 
might be binding to the components of the base, export apparatus or the ATPase complex.  The 
export apparatus (EA) consists of five integral membrane proteins that form the export channel 
in the inner membrane and are believed to recognize export substrates (29).  Among the EA 
components, the cytosolic domain of Yersinia YscV/Pseudomonas PcrD presents a possible 
target for interaction with T3SS components and chaperones (29).  Additionally the cytosolic 
domain of Yersinia YscU/Pseudomonas PscU is important in substrate switching of the T3SS 
components during secretion (29).  Hence, it is tempting to speculate that the chaperones might 
be involved in protein-protein interaction with at least these two components at the cytoplasmic 
face of the T3SS.  This interaction of the chaperones with the T3SS components hinders the 
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recognition of the effector proteins, thereby blocking secretion of the effectors.  With respect to 
the Yersinia system it is not unreasonable to speculate that LcrV initially recognizes an LcrG-
T3SS complex, and promotes the dissociation of LcrG by altering its interaction with the T3SS 
components.  This is followed by the formation of an LcrG-LcrV heterodimer, which removes 
the negative block allowing the secretion of effectors.  Thus, identification of these T3SS 
components would yield an improved understanding of secretion regulation by the Yersinia and 
Pseudomomas T3SS. 
The LcrV crystal structure reported in this dissertation is at a higher resolution of 1.65 Å 
compared to the previous structure (30) (Chapter 3).  Importantly, this structure does not have 
any mutations in the N-terminal domain of LcrV as opposed to the triple mutant 
K40A/D41A/K42A used to solve the original structure of LcrV (30).  Overall, the two structures 
are similar but there are notable differences particularly near the site of the triple mutation.  The 
refined structure reported here revealed a slight shift in the backbone position of residues Gly-28 
to Asn-43, and displayed electron density in the loop region from residues Ile-46 toVal-63 that 
was disordered in the original structure.  In addition, the helical region spanning residues Tyr-77 
to Gln-95 adopts a different orientation.  The triple mutations in 1R6F are located in the N-
terminal domain of LcrV, which forms the base of the tip complex and suggested to be involved 
in protein-protein interaction with the translocon (31).  Thus, the refined crystal structure of 
LcrV reported here with native residues in the N-terminal domain would be useful in future 
structural modeling of the LcrV-translocon interaction. 
In conclusion, the research presented herein provides the first structural characterization of the 
LcrG/PcrG family of chaperone proteins from Y. pestis and P. aeruginosa. It was not possible to 
elucidate their three-dimensional structure because of the inherent flexibility of the chaperones, 
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which likely contributes to their functional versatility.  Along with the characterization of their 
individual structures, this dissertation showed for the first time the structural effects of the 
interaction between the V-tip proteins of the bacterial T3SS and their cognate chaperones.   
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